The Glasgow Coma Scale (GSC) rating score sheet.
\r\n\t
",isbn:"978-1-83768-394-9",printIsbn:"978-1-83768-393-2",pdfIsbn:"978-1-83768-395-6",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!0,isSalesforceBook:!1,isNomenclature:!1,hash:"ee9205fd23aa48cbcf3c9d6634db42b7",bookSignature:"Dr. Tao Huang",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/12177.jpg",keywords:"DNA Methylation, 3D Genome, RNA Modification, Tumorigenesis, Early Detection Biomarker, Development, Chromatin Dynamics, Hi-C, Topologically Associating Domains, Contact Map, N6-Methyladenosine, Eraser",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"June 10th 2022",dateEndSecondStepPublish:"July 8th 2022",dateEndThirdStepPublish:"September 6th 2022",dateEndFourthStepPublish:"November 25th 2022",dateEndFifthStepPublish:"January 24th 2023",dateConfirmationOfParticipation:null,remainingDaysToSecondStep:"a month",secondStepPassed:!0,areRegistrationsClosed:!1,currentStepOfPublishingProcess:3,editedByType:null,kuFlag:!1,biosketch:"A Highly Cited Chinese Researcher with over 200 journal papers published, and a high h index (48). Dr. Huang was included in the World's Top 2% Scientist list (2020, 2021) and is the Vice President of Life Sciences, The Youth Innovation Promotion Association of the Chinese Academy of Sciences.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"461341",title:"Dr.",name:"Tao",middleName:null,surname:"Huang",slug:"tao-huang",fullName:"Tao Huang",profilePictureURL:"https://mts.intechopen.com/storage/users/461341/images/system/461341.jpg",biography:"Tao Huang is an Associate Professor at Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences. He completed his post-doctoral research at the Department of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai, New York City, USA. His research interests include bioinformatics, computational biology, systems genetics, and big data research. He has published over 200 articles. His works have been cited 10,144 times with an h-index of 48. He has edited books of Computational Systems Biology: Methods and Protocols and Precision Medicine for Methods in Molecular Biology series. He has been Editor or Guest Editor for over 30 journals and a Reviewer for 170 journals. He is a Highly Cited Chinese Researcher (2020) and World's Top 2% Scientist (2020, 2021).",institutionString:"Chinese Academy of Sciences",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Chinese Academy of Sciences",institutionURL:null,country:{name:"China"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"6",title:"Biochemistry, Genetics and Molecular Biology",slug:"biochemistry-genetics-and-molecular-biology"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"444315",firstName:"Karla",lastName:"Skuliber",middleName:null,title:"Mrs.",imageUrl:"https://mts.intechopen.com/storage/users/444315/images/20013_n.jpg",email:"karla@intechopen.com",biography:"As an Author Service Manager, my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"6694",title:"New Trends in Ion Exchange Studies",subtitle:null,isOpenForSubmission:!1,hash:"3de8c8b090fd8faa7c11ec5b387c486a",slug:"new-trends-in-ion-exchange-studies",bookSignature:"Selcan Karakuş",coverURL:"https://cdn.intechopen.com/books/images_new/6694.jpg",editedByType:"Edited by",editors:[{id:"206110",title:"Dr.",name:"Selcan",surname:"Karakuş",slug:"selcan-karakus",fullName:"Selcan Karakuş"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2270",title:"Fourier Transform",subtitle:"Materials Analysis",isOpenForSubmission:!1,hash:"5e094b066da527193e878e160b4772af",slug:"fourier-transform-materials-analysis",bookSignature:"Salih Mohammed Salih",coverURL:"https://cdn.intechopen.com/books/images_new/2270.jpg",editedByType:"Edited by",editors:[{id:"111691",title:"Dr.Ing.",name:"Salih",surname:"Salih",slug:"salih-salih",fullName:"Salih Salih"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"117",title:"Artificial Neural Networks",subtitle:"Methodological Advances and Biomedical Applications",isOpenForSubmission:!1,hash:null,slug:"artificial-neural-networks-methodological-advances-and-biomedical-applications",bookSignature:"Kenji Suzuki",coverURL:"https://cdn.intechopen.com/books/images_new/117.jpg",editedByType:"Edited by",editors:[{id:"3095",title:"Prof.",name:"Kenji",surname:"Suzuki",slug:"kenji-suzuki",fullName:"Kenji Suzuki"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3828",title:"Application of Nanotechnology in Drug Delivery",subtitle:null,isOpenForSubmission:!1,hash:"51a27e7adbfafcfedb6e9683f209cba4",slug:"application-of-nanotechnology-in-drug-delivery",bookSignature:"Ali Demir Sezer",coverURL:"https://cdn.intechopen.com/books/images_new/3828.jpg",editedByType:"Edited by",editors:[{id:"62389",title:"PhD.",name:"Ali Demir",surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"872",title:"Organic Pollutants Ten Years After the Stockholm Convention",subtitle:"Environmental and Analytical Update",isOpenForSubmission:!1,hash:"f01dc7077e1d23f3d8f5454985cafa0a",slug:"organic-pollutants-ten-years-after-the-stockholm-convention-environmental-and-analytical-update",bookSignature:"Tomasz Puzyn and Aleksandra Mostrag-Szlichtyng",coverURL:"https://cdn.intechopen.com/books/images_new/872.jpg",editedByType:"Edited by",editors:[{id:"84887",title:"Dr.",name:"Tomasz",surname:"Puzyn",slug:"tomasz-puzyn",fullName:"Tomasz Puzyn"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"58504",title:"Management of Intracranial Pressure in Traumatic Brain Injury",doi:"10.5772/intechopen.72829",slug:"management-of-intracranial-pressure-in-traumatic-brain-injury",body:'\nThe onset of increased intracranial pressure is often attributed to many pathologies such as large artery acute ischemic stroke, intracranial neoplasms, or disorders such as meningitis. The most common reason for which the onset of intracranial pressure is observed is due to traumatic brain injuries, such as colliding one’s head into a hard object as a result of an accident. By definition, an intracranial pressure that exceeds 20 mm Hg is considered high and indicative for the need of immediate treatment [1]. Through the advancement of medicine and technology, the variety of treatment options available to relieve patients of increased intracranial pressure has grown tremendously. In practice today, there exists a multitude of treatment options ranging from nonsurgical interventions to surgical interventions [2, 3]. In this chapter, we will discuss the primary pathology of patients presenting with increased intracranial pressure (ICP) as a result of traumatic brain injuries (TBIs), and we will take a generalized perspective on this pathology by discussing a multitude of topics we find crucial to your understanding of the management of ICP in TBI patients.
\nTraumatic brain injury (TBI) is composed of an external mechanical force, whether it be a change in acceleration or impact by projectile that causes a temporary or at times a permanent brain function impairment as well as physical damage to the human brain anatomy. It is important that we establish a clear understanding of the term TBI and its partnering term non-TBI. A traumatic brain injury is brought on by the impact generated by an external force, while a nontraumatic brain injury is brought on by internal forces such as a stroke or infection. A traumatic brain injury, which we have now learned arises from external forces, can come in two pathological forms: penetrating and nonpenetrating. This classification presents as simply as it is defined. A penetrating TBI results in several lesions starting from one’s head down to the cerebral level, and these often occur in severe accidents or injuries. A clear and prime example of a penetrating TBI is one that occurs all too often to members of our military, a foreign projectile being discharged from an external high-force machine, which then strikes a human head [4]. A nonpenetrating TBI is the form that we will cover more in depth within this chapter and results from an external force acting upon the head, but it does not penetrate any layer of human anatomy. Within the clinic, the formal classification of TBIs may be reduced to open-head injury for patients presenting with traumatic brain injuries of the penetrating type, and for patients presenting with a traumatic brain injury of the nonpenetrating type, the term closed head-injury may be assigned [5]. The simplification made to these terms adds an element of simplicity for when medical professionals present cases to patient’s families and loved ones.
\nTo aid in our understanding of traumatic brain injuries and later on the rise of intracranial pressure, it is imperative we touch upon the anatomy of the human brain such that successive sections of this chapter can be understood with a greater degree of clarity. The human brain, the core of the central nervous system, controls a vast majority of bodily processes and functions. The center of knowledge and core processing is perhaps the most important regulator of human life, yet only weighs between three to five pounds. The first line of defense for the brain is called the cranium, often referred to as the skull, and this shields the brain with a tough bone structure [6]. The brain covering itself contains three layers: the dura, arachnoid and pia. Interestingly enough, there also exists a space between the pia and arachnoid referred to as the subarachnoid complex. This area houses a vast network of veins, arteries, and nerves, which channels both blood and electrochemical potential to the heart and back to the brain. This subarachnoid complex is prone to trauma as well as constriction or full blockage. Any trauma that may cause constriction or blockage will also pose a greater threat to the tissue of the brain. Thus far, we have discussed the cranium and the brain that it encloses; however, the brain does not fill the entire volume of the cranium, and the volume remaining is filled by cerebrospinal fluid (CSF), serving as a nutrient-rich cushion around the brain, and blood-vessels. It is important to note that the volume of the cranium is fixed, and the brain fills a fixed volume of the cranium and the cerebrospinal fluid (CSF); therefore, any trauma that may alter the volume of the cranial region can be devastating, a concept referred to as increased intracranial pressure (ICP), which we will discuss in immense detail throughout this chapter [7].
\nA common misconception we wish to clear up is the designation of the upper and lower brain, and it is often misunderstood that the brain is a term used only for the upper brain, the ovular shaped region; however, the lower brain that houses vital components such as the brainstem is also indeed part of the human brain. At the lowest point of the brain (brainstem), there exists a small circular opening for which the skull and the spinal cord merge to form the complete central nervous system. As we mentioned above, the brainstem in fact is one of the most important parts of the lower brain as it houses a plethora of intricate nerve fibers, which pass information from the brain to the spinal cord and to the body as a whole. Another crucial component of the lower brain is the cerebellum, a small mass of neuronal tissue that is responsible for the regulation and coordination of motor skills and balance. Without this region of the brain, the miracle of the human touch, whether it be the detailed touch of an artist or the intricate lifesaving work done at the microscopic level by a neurosurgeon, will not be possible. The ovular region of the human brain, known as the upper brain, is a large mass of neuronal tissue divided into white and gray matter. Gray matter houses neuronal cell bodies, axons, and dendrites, while white matter is entirely made up of axons, which connect other gray matter components together [8]. The upper brain is composed of the cerebral cortex, which is the largest component of the human brain, and this region is divided into two hemispheres: left and right. Uniquely enough, the right side of the brain will control left side of the body and vice versa. Despite the left and right hemisphere designations of the cerebral cortex, there are also various other designations called regional designations, and these include the frontal lobes, temporal lobe, parietal lobe, and occipital lobe. The frontal lobes are comprised of the left and right lobes, which are located directly behind the forehead, and these control one’s intellectual abilities, decision making, behavior, and emotions. The temporal lobe is behind the ear and extends to the center of the head; from a bird’s eye view of the brain, it is directly behind the frontal lobe and extends outward from both ears. This lobe controls speech, understanding, memory, and information retention [9]. Our ability to read, write, and understand spatial relationships is due to the efforts made by the parietal lobe, which is located at the rear of the head, specifically the upper section of the convex ovular protrusion site. Also at the rear of the head, but significantly lower, is the occipital lobe, which controls sight. While we have covered the brain as a whole, it is important to note that throughout the cerebral cortex there are also several sites that are denoted by specific names, which we will discuss when the pathology becomes relevant to those particular areas, and these sites are rich in nerves and also house nerve centers. These are called diencephalons; a more notable diencephalon is the hypothalamus, which regulates homeostasis of the body. These include control over body temperature, hunger, thirst, and arousal. Why discuss the anatomy of the brain to this extent? We hope that since we have discussed anatomy to this extent, the discussion of traumatic brain injury to regions of the brain can be better understood. Damage to any area of the brain can result in both impairment to the functions they regulate and permanent damage to the physical anatomy leading to cognitive deficiencies as well [10, 11].
\nThe immediate identification of traumatic brain injuries is crucial for the positive-outlook prognosis of a patient, and injuries of this nature present in a spectrum of severities each consisting of unique clinical presentations. To simplify the spectra of severity, a classification system has been established that rates injuries in three categories: mild, moderate, and severe. This classification system is called the Glasgow Coma Scale (GSC), a system readily utilized for the classification of thousands of traumatic brain injury cases per year [12]. The Glasgow Coma Scale is used in evaluating a patient’s level of consciousness based on a sum of several categories ranging between 3 and 15. Evaluation of patient consciousness is based upon his or her responsiveness to general verbal, visual, and motor stimuli [13]. The numerical score of this assessment will classify the severity of a patient’s brain injury; a score closer to 15 demonstrates near-full neurological ability and consciousness, while a score closer to 3 demonstrates a case in which severe brain injury has occurred and the patient is in a deep coma. A Glasgow Coma Scale score of 13–15 indicates a mild brain injury, while a score of 9–12 indicates a moderate brain injury, and any patient scoring 8 or below is said to have incurred a severe brain injury [12, 14]. Table 1 demonstrates the rating categories medical staff use to generate a Glasgow Coma Scale score.
\n\n | 1 | \n2 | \n3 | \n4 | \n5 | \n6 | \n
---|---|---|---|---|---|---|
Visual | \nEyes closed | \nEyes open to sharp stimuli | \nEyes open to sounds | \nEyes open without induced stimuli | \n\n | \n |
Motor | \nNo movement | \nMovement to sharp stimuli | \nMuscle flexion to sharp stimuli | \nMuscle flexion and bodily movement | \nAble to localize touch | \nAppears to have normal movement | \n
Verbal | \nNo sounds | \nSlow intensity sounds | \nIncoherent words | \nUnderstandable words spoken | \nNormal conversation | \n\n |
The Glasgow Coma Scale (GSC) rating score sheet.
To generate the Glasgow Coma Scale (GSC) score, a score will be determined for each category, followed by the summation of all three categories to generate a score between 3 and 15.
\nAn accumulation of pressure above the normal standard within the skull is denoted as elevated intracranial pressure (ICP), a severe condition that requires immediate remediation. While the initial cause for the onset of ICP may vary greatly from patient to patient, the anatomical factors that play a role in intracranial pressure are simply the cranium, the brain, and the cerebrospinal fluid that fills the volume in between the cranium and the brain. Within medicine, the standard unit to measure pressure is “mm Hg,” which stands for millimeters of mercury, the distance mercury travels in a closed system to indicate pressure. For a normal adult, at rest, and in good health, the intracranial pressure should remain between 6 and 16 mm Hg [15]. A unique high-order organismal advantage humans possess is the ability to maintain homeostasis, much like many functions of the body, and homeostasis is crucial to the long-term survival of the human. Within the brain, there are also many hemostatic mechanisms in place to maintain a healthy and acceptable pressure within the cranium. The management of intracranial pressure is in fact done through the regulation of the metabolism and production of cerebrospinal fluid (CSF). Since CSF is the only liquid occupying the volume between the cranium and brain, there is no other regulation factor that the body can maintain. The size of the brain and skull only grows slightly after birth and cannot be altered freely to reduce pressure; thus, the regulation of CSF metabolism and production are crucial in maintaining a healthy and acceptable intracranial pressure [16]. In the event that intracranial pressure rises to the limits of the normal and healthy range, immediate remediation is necessary. When the ICP reaches 17–18 mmHg, concern should be raised, and when ICP ranges between 19 and 25 mmHg, immediate relief of pressure is required to prevent damage to regions of the brain [17].
\nThe Monro-Kellie hypothesis was proposed by Doctors Alexander Monro and George Kellie in correspondence to the impact cerebrospinal fluid (CSF) has on the pressure-volume relationship within the cranium. This particular hypothesis describes the intracranial volume-pressure relationship, which we briefly mentioned above. According to the Monro-Kellie hypothesis, the fixed volume of the cranium is comprised of the brain, cerebrospinal fluid, blood, and the pressure of blood flowing to the brain called cerebral perfusion pressure (CPP). Within the fixed volume, the cranium and all components within come to form a state of equilibrium, which we discussed as homeostasis. This hypothesis states that an increase in volume of any one of the cranial constituents results in an increase of pressure within the cranium unless there is an equal or greater reduction of volume in another cranial constituent [18]. Buffers within the cranium respond to increases in cranial constituent volume in hopes to reduce pressure to avoid brain damage. In the event that cranial pressure rises, typically due to an increase in lesion volume, a decrease in blood and cerebrospinal fluid is observed in hopes to reduce intracranial pressure [19].
\nThe most common cause of increased intracranial pressure, also known as intracranial hypertension, is traumatic brain injuries. The neurological complication that is accompanied by a traumatic brain injury is the loss of pathophysiologic regulators of the brain that results in deregulation of intracranial pressure management [20]. The volume of an average adult’s skull is approximately 1500 mL, in which over 85% is occupied by the brain, 10% by arterial blood, and 5% by cerebrospinal fluid [21]. Cerebral profusion pressure (CPP), which we briefly mentioned above as the pressure created by cerebral blood flow, is dependent on two factors: both mean systemic arterial pressure (MAP) and ICP. Mean systemic arterial pressure (MAP) and intracranial pressure (ICP) are related to cerebral perfusion pressure (CPP) based on the relationship that: CPP = MAP – ICP. Mean systematic arterial pressure (MAP) is calculated by the summation of one-third systolic blood pressure (SBP) and two-thirds diastolic blood pressure (DBP), in abbreviated form as: MAP = 1/3 SBP + 2/3DBP [22]. In line with the Monro-Kellie hypothesis, an increase in intracranial pressure (ICP) is remediated physiologically by a decrease in cerebral perfusion pressure (CPP) [23]. Through the relationship we described above, a decrease in CPP dictates that there is a decrease in blood pressure and therefore autoregulation of intracranial pressure. While a decrease in CPP regulates ICP, it is also vital that a minimum CPP be maintained such that the brain can receive adequate amounts of blood. Normal CPP ranges between 50 and 165 mmHg, and in the event that CPP drops below 50 mmHg, the brain will not receive adequate amounts of blood, thus creating further complications with maintaining normal cerebral blood flow [24]. When the brain is subjected to injury, the physiological homeostatic functions of the brain may be deregulated or not functional at all. A normal pathology will maintain the normal CPP of 50–165 mmHg while regulating an appropriate ICP level as well. In the event that the intracranial pressure (ICP) rises past 16 mmHg, blood vessels within the brain will constrict to reduce the blood to flow to cranium thus lowering the intracranial pressure. Thus, when a traumatic brain injury occurs, to the extend where the brain’s homeostatic functions are lost, intracranial pressure (ICP) increases and physiological regulatory functions are nonoperable [25].
\nThe management of an increased intracranial pressure is vital for the successful outcome of the patient. In the event that an elevated intracranial pressure goes untreated, two major complications arise. The first is the temporary or permanent loss of vision (depending on severity) and the second is development of a severe headache that lasts for more than 48 hours [26]. Additionally, patients will also begin to exhibit irritability, lethargy, slow cognitive processes, as well as abnormal behavior. Untreated elevated intracranial pressure may subject the patient to enter a state of near-unconsciousness, coma, or even death [27]. Another concern for patients presenting with elevated intracranial pressure is the possibility for damage incurred through brain herniation. Brain herniation is a deadly condition that arises when the ICP is extremely high, and this condition presses the brain tissue against the hard cranium causing compression damage to the brain. This extreme pressure may also cause the brain to shift across vital structures that connect the brain to the spinal cord, such as the falx cerebri [28]. While brain herniation may also occur in the absence of an elevated ICP, it is more frequently seen in patients that do in fact present with a severely elevated ICP. High pressure within the cranium induces brain herniation and that can constrict or block arterial blood flow to various parts of the brain, proving to be fatal. In Figure 1, the CT scan of a patient presenting with left-side brain herniation of the parahippocampal gyrus, a structure of the brain that is paramount in memory encoding and memory retrieval, is shown, and damage to this area may result in memory disturbances and schizophrenia [29].
\nCT scan demonstrating brain herniation on left side due to temporal lobe hemorrhage [
Patients presenting with elevated intracranial pressure (ICP) resulting from traumatic brain injury (TBI) exhibit symptoms very much similar to patients presenting solely with elevated ICP due to other factors. Traumatic brain injury patients, depending on severity, will present with a series of symptoms that are generally along the lines of unconsciousness/coma, headache, vomiting, nausea, compromised motor function, blurred vision, headache, perception of noise that is not present (ringing sounds), as well as difficulty keeping balance. The one symptom we did not mentioned above that we will discuss in depth now is elevated intracranial pressure resulting from traumatic brain injury. Alongside all the symptoms a TBI patient will exhibit, ICP will also cause several symptoms to be present much similar to those already seen in TBI patients [30]. Typical elevated ICP patients present clinically with headache, vomiting, nausea, reduced state of consciousness, and vision blurriness. Figure 3 demonstrates the overlap of the symptoms a TBI patient will exhibit versus symptoms an elevated ICP patient will exhibit. But do note that a common symptom of a TBI patient is in fact also elevated ICP, but elevated ICP in not only brought on my a TBI, and other factors may contribute to elevated ICP such as hydrocephalus and intracranial hemorrhage [33].
\nNow that we understand the clinical features of traumatic brain injury (TBI) patients as well as elevated intracranial pressure (ICP) patients, let us combine the two as one pathology, elevated intracranial pressure due to a traumatic brain injury. Referring back to Table 2, we know how similar the presenting symptoms may be; thus, let us briefly discuss how a diagnosis may be made. First and foremost, if the history of the patient prior to clinical presentation involves any form of trauma to the head, a TBI can be easily diagnosed. The next step will be to conduct a neurological evaluation, often using the Glasgow Coma Scale (GCS). A symptom of a TBI may be elevated intracranial pressure (ICP), which can be diagnosed primarily through a neurological exam conducted by a neurologist or neurological surgeon. Additionally, radiological imaging via computed topography (CT) scan and magnetic resonance imaging (MRI) can be utilized to determine the presence of the cause as well as the severity of the elevated intracranial pressure [34].
\nClinical presentation | \nTBI patient | \nICP patient | \n
---|---|---|
Coma—unconsciousness | \nPresent | \nPresent | \n
Headache | \nPresent | \nPresent | \n
Vomiting—nausea | \nPresent | \nPresent | \n
Reduced motor function—balance | \nPresent | \nPresent | \n
Vision deficits—blurriness | \nPresent | \nPresent | \n
Ringing of ear | \nPresent | \nNot Present | \n
Elevated intracranial pressure (ICP) | \nPresent | \n
Comparison of TBI and ICP symptoms.
Radiographic imaging to determine the presence of a traumatic brain injury that results in the onset of elevated intracranial pressure is crucial for the high-certainty diagnosis medical professionals seek to provide. Radiographic methods utilized in the diagnostic process are CT scans and MRI, and over the years, a series of common trends have been documented in regard to radiological findings, which we will discuss in this section. In Table 3, we highlight the core radiological findings that we will discuss in this section.
\nRegions of common trends in radiological findings | \n
---|
Optic nerves | \n
Bilateral venous sinus stenosis | \n
Lesioned ventricles | \n
Enlarged arachnoid | \n
Cerebellar tonsil | \n
Subdermal adipose tissue accumulation | \n
CT and MRI radiological findings for ICP resultant of TBI.
The second cranial nerve, also known as the optic nerve, transmits visual information from the retina through a complex nervous network to the brain. This cranial nerve develops from optic stalks during early embryonic development and is supported by nonneuronal glial cells [35]. In patients presenting with elevated intracranial pressure, the optic nerve region of the CT and MRI scan shows a clear area of prominence. Within this region, approximately 40% of elevated ICP patients present with optic nerve tortuosity, a condition in which optic nerve is twisted or alerted slightly from physiologically normal conditions [36, 37]. In approximately 45% of patients, the subarachnoid space surrounding the optic nerve is highly prominent and protrudes the space of the optic nerve [38]. This region is comprised of delicate connective tissue as well as channels that contain cerebrospinal fluid (CSF), and this region plays a role is creating channels for intercommunication between the arachnoid, the pia mater, and the CSF. The optic disk, also referred to as the optic nerve head, is the terminal point for ganglion cells leaving the eye. The region is a physiologically normal blind spot each eye possesses due to the lack of photoreceptors, rods, and cones in that region [39]. A condition involving the swelling of optic disk is called papilledema, and in patients that present with elevated ICP, this is a common occurrence [40]. Due to the fact that the optic disk is continuous with the subarachnoid space, swelling of this region contributes greatly to elevated intracranial pressure. This swelling can manifest itself into two forms: either as an intraocular protrusion of the optic nerve or as seen in a vast majority of papilledema patients, a flattening of the posterior white of the eye, sclera [41]. InFigure 2, the nodular enhancement of the optic nerves is seen, from a case study on irregular papilloedema [42]. The last pathology we will discuss in relevance to the optic nerve is the MRI enhancement of the intraocular optic nerve, which is anterior to the sclera’s lamina cribrosa. This pathology is seen in approximately 50% of elevated ICP due to TBI and adds to the intracranial pressure via degeneration of optic nerves, causing damage to axonal components leading to increased ICP and irreversible blindness in a vast majority of glaucoma patients [43].
\nPapilledema, enhancement of optic nerve leading to increased ICP [
Another pathology consistent with the increase in intracranial pressure is bilateral venous sinus stenosis, which may be prevalent in segments of the transverse sinus. Stenosis involves the constriction of a venous tract, in this case of the sinus [44].
\nPseudotumor cerebri (PTC) is a clinically relevant pathology that presents with increased intracranial pressure, but the etiology is not entirely understood. This syndrome tends to target women over men, and specifically obese women. PTC, as mentioned above, results from increased ICP and presents clinically with headaches, nausea, as well as changes in vision. Through radiographic efforts, this pathology is linked with elevated CSF, a connection that was dismissed in the earlier years of medicine. Interestingly enough, patients with elevated ICP who also present with PTC have the following pathologies: an empty sella, an enhancement of the optic nerve head, and a tortuosity of the optic nerve [45]. An empty sella, otherwise known as empty sella syndrome (ESS), is where the pituitary gland is physically altered, and thus the sella turcica becomes filled with CSF [46]; see Figure 3. ESS is usually highly indicative of an increased intracranial pressure.
\nSagittal T2-weighted image of ESS in an elevated ICP patient [
Thus far, we have discussed three of the most common radiological findings, in a nonspecific order. The next pathology we will discuss is the enlargement of the arachnoid resulting from an increase of ICP due to TBI. ESS, or empty sella syndrome, we just discussed also plays a major role in the enlargement of the arachnoid. Actually, approximately 70% of enlarged arachnoid cases due to increased ICP are because of empty sella syndrome, replacing the void volume of the pituitary gland with CSF [47, 48]. Some cases of arachnoid enlargement are attributable to an enlarged Meckel cave [49]. The Meckel cave, previously known as the trigeminal cave, is a CSF-filled arachnoid pouch, which protrudes from the posterior cranial fossa, the most posterior segment of the cranium base where the cerebellum and brainstem reside. In the event of a TBI, cerebrospinal fluid (CSF) fills into this cavity, expanding the volume of this cavity, resulting in an increase of intracranial pressure due to the narrow and space-limited anatomy of this brain region [50, 51].
\nThe next pathology that we will discuss that is commonly observed in radiological investigations of increased ICP in TBI patients is tonsillar ectopia, synonymous to cerebellar tonsils, a disorder of the papa-axial mesoderm. In this pathology, the cerebellar tonsils elongate due to pressure, leading the cerebellum to be pushed through the foramen magnum of the cranium resulting in additional increased intracranial pressure as well as tonsillar herniation [52]. This condition is life threatening, as cranial pressure is heavily diverted onto the medulla oblongata, a vital sector of the brain that controls cardiac and respiratory functions [53, 55].
\nAs we have now discussed the most common radiological presentation for patients presenting with increased intracranial pressure due to a traumatic brain injury, we will begin our discussion on the treatment pathways to remediate these issues. Management and treatment for increased intracranial pressure can utilize both a nonsurgical and surgical intervention, and in the sections to follow, we will discuss both management options.
\nNonsurgical management of increased intracranial pressure can take on a multitude of forms. In this section, we will discuss the many medicinal options available to patients presenting with increased intracranial pressure resulting from a traumatic brain injury. The quickest and least invasive method to reduce a patient’s ICP to a normal range is by elevating the patients head to 30° with respect to the horizontal plane [56]. The elevation of a patient’s head does not directly act toward lowering the ICP; in fact, an elevated head aims to reduce CPP, which in turn reduces ICP by increasing venous drainage (based on the relationship we discussed in an earlier section of this chapter) [57]. A common practice typically conducted by first responders to patients that show clear signs of a traumatic brain injury and increased intracranial pressure in the field is to medically induce a state of minimal hyperventilation. In 1970, hyperventilation of a patient with an increased ICP was a common practice and used readily, and it was not until a study came out stating the adverse outcomes of a prolonged state of hyperventilation; in fact, it was shown to have caused cerebral ischemia, a condition where an insufficient amount of blood is delivered to the brain. Today, hyperventilation is still used in the treatment of an increased ICP but only to a pCO2 level of 25 mmHg. Immediate initial treatment may call for the hyperventilation of a patient to pCO2 levels of 30–40 mmHg but for no greater than 2–5 min, before returning back to 25 mmHg. More often than not, hyperventilation is not necessary for the treatment of an increased ICP, and there are better methods that were developed compared to the hyperventilation that was introduced in the 1970s [58, 59]. An organic biological medication, mannitol, which is a sugar alcohol typically administered intravenously is used to decrease high blood pressure in the eyes as well as to decrease intracranial pressure [60]. With effects seen 10–20 min after administration and lasting up to 8–10 h, mannitol is metabolized by the liver and excreted mostly by the kidney. Mannitol has a biological half-life of 100 min and is mostly a synthetic drug, with only a 7% bioavailability [61]. The biochemical mechanism by which mannitol acts on human physiology is bimodal, meaning the drug can mechanistically act in two ways. The first pathway is to lower osmotic diuresis through the reduction of swelling within the cerebral parenchyma. The second pathway is to lower the viscosity of the blood, therefore allowing for more laminar blood flow through veins and arteries eventually causing a state of vasoconstriction, which decreases the intracranial volume of blood and thus a lowered intracranial pressure [62, 63]. The mechanistic bimodal action by mannitol makes the drug a popular choice among patients presenting with an increased ICP due to TBI [64]. A class of drugs known as barbiturates has been widely debated in its effects on lowering intracranial pressure, while this class of drugs can successfully complete the task at hand, the use of barbiturates often causes a state of decreased myocardial function and decreased CPP, which can cause higher rates of morbidity and mortality if left unmonitored. Thus, we do not advocate the use of barbiturates as a drug for the treatment of elevated ICP, unless as a last resort option. For your understanding, a barbiturate is a synthetic chemical drug that acts as a depressant of the central nervous system capable of producing a wide spectrum of effects [65]. While barbiturates are not a recommended class of drugs to utilize in the treatment of elevated ICP due to TBI, it in fact can and has been utilized as a last resort option for a procedure called “barbiturate-induced coma,” which aims to immediately reduce intracranial pressure in patients that are unresponsive to any other form of nonsurgical medical treatment. The barbiturate of choice for this procedure is pentobarbital, which requires electroencephalogram (EEG) monitor during intravenous use. While using this drug, it is of key importance to monitor the blood pressure of the patient such that the patient does not slip into a hypotensive state. Hypotension resulting from the use of a barbiturate dramatically increases the rate of mortality two-fold, from 25 to 50% mortality [66]. In addition to the intravenous medication administered to patients presenting with increased ICP due to TBI, the administration of a hypertonic solution to maintain a state of euvolemia, a condition in which bodily liquid volume, viscosity, and circulation are all normal, is also imperative. These hypertonic solutions depend on the results of a complete blood diagnostic panel and differ from patient to patient, and the most common intravenous hypertonic solution administered is a 0.8–8% NaCl solution [67]. In patients where intravenous euvolemia cannot be established and maintained, remediation of coagulopathy must be placed as a medical team’s highest priority [68]. Coagulopathy is a state in which the blood’s ability to coagulate is diminished or impaired, resulting in a variable viscosity of the blood and therefore further complications in the treatment of elevated intracranial pressure. Normal human physiology tightly regulates the viscosity of blood and its coagulating ability, and in patients that have suffered a traumatic brain injury, the release of biochemical pathway intermediate, thromboplastin, causes abnormal blood clotting. These abnormal clotting factors can be fatal if not remediated quickly; therefore, blood transfusions for these patients is the quickest and most preferred method in correcting blood coagulating abilities and eliminating coagulopathy. Patients on anticoagulating mediations due to high cholesterol, such as heparin or warfarin, who sustain a traumatic brain injury that results in elevated intracranial pressure are typically at risk and thus require immediate blood transfusion [69]. Approximately 1 in 10 TBI patients that present with elevated ICP also demonstrates a fever 24–48 hours after the initial injury, and this elevation in temperature is in fact part of the body’s inflammatory response [70]. Often in patients where the hypothalamus has been damaged, elevated body temperature is noticed due to an underlying infection of the region. While the biochemical mechanism of this observation is not understood, what is understood is that immediate elimination of the infection is required for a successful recovery. This unexplained fever is often called “neurological fever,” and unlike a fever caused by a cold or viral infection, neurological fever tremendously increases metabolic demand [71]. In patients with GCS scores less than or equal to 8 with imaging that demonstrates signs of cerebral edema, placement of external ventricular drain in a sterile fashion is recommended to allow CSF drainage. This procedure can be completed at bedside or in the operating room with the overall goal of decreasing cerebral edema by CSF drainage. In cases where intracranial pressure remains at or above 22 mmHg, despite all strategies discussed above, surgical intervention will need to be considered. In this section, we have discussed the nonsurgical and medicinal approach in resolving an elevated intracranial pressure; however, in any remedy for the management of ICP, it is important to remember that the overall goal is to reduce and prevent any agitation of the intracranial region. In the section to follow, we will discuss the surgical option for the management of intracranial pressure in the event that nonsurgical interventions do not remediate the issue.
\nImmediate and rapid surgical care of patients presenting with elevated intracranial pressure due to a traumatic brain injury is vital for the positive prognosis of the patient, especially if nonsurgical routes did not suffice in the remediation of intracranial pressure. Intracranial lesions resulting in an increased ICP typically present in patients as a state of reduced consciousness, and this pathology requires a surgical procedure called “rapid decompression.” This surgery is self-explanatory at the elementary level, as the surgical efforts aim to reduce intracranial pressure (“decompress”) and do so as soon as possible. Prior to operation, a complete patient profile must be reobtained, meaning that radiological evidence alone is not enough to proceed with decompression surgery; a neurological examination coupled with radiological evidence that is convincing without any doubt is what surgical staff must aim to achieve. Similar to many forms of surgery, patient age plays a major role. For decompression surgeries, patients that are young (12 years old or younger) or elder (70 years old or older) pose a greater risk to surgical harm, and this harm is referred to as intracranial hemorrhage, excessive bleeding from tissue and venous tract within the intracranial region [72]. The first form of decompression surgery that we will discuss is decompressive craniotomy, a procedure in which a segment of the cranium is removed to relieve intracranial pressure and to create additional room for the brain swelling. This decompressive surgery evolved from a primitive form of surgery called trephining. Today, this surgical practice is a last resort option and has been more successful in younger patients rather than in older patients, another surgical option is craniotomy for evacuation of focal hemorrhage which can be subdural, epidural or intraparenchymal in nature [73]. The next surgical practice we will discuss that is used in the treatment of elevated intracranial pressure due to a TBI, which causes an over production of CSF, is a ventriculoperitoneal (VP) shunt. A VP shunt is a medical device that relieves pressure from the brain due to fluid accumulation, and this shunt drains the excess fluid and allows it to be metabolized and reabsorbed. Normally, CSF will coat the brain and spinal cord and be reabsorbed into the blood, and in a disrupted flow, the CSF can build up and create pressure on the brain causing damage. A common source for deregulation for CSF production and reabsorption is traumatic brain injury, and in these cases, it is common for CSF to cause damage to the brain [74]. Prior to surgery, a patient will be instructed to halt any consumption of food and water by mouth (PO) at least 8–12 h before surgery. Then a surgical nurse will prepare the area behind the ear for surgical incision. The shunt is a catheter, a thin flexible but heavy-duty tube that is used to drain excess liquid. A neurological surgeon will then make a small incision behind the ear and using a burr-drill will create a small hole within the patient’s scalp [75]. With the hole in the cranium, surgical staff will insert one catheter into the brain and another subdermal catheter will be placed behind the ear. A thin tube will travel down the patient’s torso and into the abdominal cavity. The excess CSF will drain into the abdominal cavity relieving intracranial pressure [76]. In patients that present with intracranial pressure regularly, a pump may be placed to activate this channel when ICP rises. For the context in which we have been discussing, this shunt will be used to relieve patients of increased ICP following a TBI.
\nManagement of elevated intracranial pressure due to a traumatic brain injury requires the utilization of many forms of medication. Thus far, we have discussed a few drugs that directly target elevated intracranial pressure, but often these pathologies require surgical intervention. For that to occur, a wide variety of drugs must be utilized to stabilize the patient from common complications that arise. In this section, we will touch upon the class of drugs utilized prior to neurological surgery. The most prevalent presurgical complication presenting in medical centers today is intracranial hemorrhages; see Figure 4. Intracranial hemorrhages denote bleeding of the brain; medical personnel often utilize prophylactic anticonvulsants, and the term prophylactic refers to the act of committing an action before hand and the term anticonvulsants refers to a set of pharmacological drugs that block sodium channels or enhance GABA (gamma-aminobutyric acid) function [78, 79]. Physiologically, these drugs can save a life in the event of a seizure as well as reduce bleeding in the brain prior to surgery [80]. There are many drugs that can be used that are considered in this pharmacological class, and the first of its kind was discovered in 1882 (paraldehyde); today, the drug of choice is phenytoin or fosphenytoin [81]. In adults, a loading dose of phenytoin or fosphenytoin is administered, typically in adults 18 mg anticonvulsant per kilogram (kg) of patient body weight. Then, therapeutic levels of 20 milligram (mg) per deciliter (dL) are maintained until intracranial hemorrhage subsides [82]. Prolonged use of anticonvulsant drugs may result in gingival hyperplasia, an enlargement of one’s gingiva (commonly known as gums) as well as randomized hair growth in men and unwanted male-hair growth in women, known as hirsutism [83–85]. In the unfortunate case where a pediatric patient is subjected to elevated intracranial pressure due to a traumatic brain injury that is accompanied by intracranial hemorrhage, the drug of choice changes to phenobarbital, where a 20 mg/1 kg body weight loading dose is given, followed by a therapeutic dose of 10–50 mg/dL.
\nCT scan of subdural in a TBI patient presenting for surgical intervention [
Many patients that present to medical centers for treatment of mild to severe traumatic brain injury and are subjected to an elevated intracranial pressure will tremendously benefit from numerous outpatient care options. As traumatic brain injury patients typically have difficulty with daily tasks, physical and occupation therapy is highly recommended as patients try to regain a normal lifestyle. Additionally, times following a traumatic incident can be hard emotionally and spiritually, and thus it is also beneficial for patients to receive counseling care from professional as well as from family and loved ones. The initial efforts to reestablish the life the patient once had is difficult and both mentally and physically taxing, and support and counseling are of key essence.
\nThroughout this chapter, we have discussed the many applications and forms of medical care pertaining to the presence of elevated intracranial pressure resulting from traumatic brain injury. Throughout this chapter, we hope that you have learned the key diagnostic characteristics, medical treatment, and future outcomes for patients experiencing this traumatic pathology. While we hope no patient has to suffer from TBI, we wish all medical staff best of luck in their efforts to remediate these conditions and for continual excellence in patient care.
\nAll figures displayed within this manuscript were obtained through the Open Access Biomedical Image Search Engine, with the image owners receiving appropriate citation for the contributions. In accordance to the terms of the Creative Commons Attribution License, the reproduction and distribution of each figure used in this manuscript are accompanied by the citation of the original author(s) or licensors. Original publication within their respected journals is also cited. Our intended uses of these figures are in good and accepted academic practice.
\nImagine that you are a manager in a large organization. You ask your subordinate employee for her help with a new project, but she refuses to help out because she has been working on a tight deadline and currently, she does not have any time for extra tasks. You are annoyed by the employee’s reaction and there has been tension between you two ever since. You ask her to meet up and discuss… How do you think the meeting will go? How will you react to the employee and how do you think that the employee will respond?
A key element to take into account before trying to think of possible answers to these questions is that between the two persons, you and the subordinate employee, there is one big difference: power asymmetry. You, manager, have power over the employee, which enables you to punish, reward, or enforce your will to her, whereas the employee does not have power over you. Power asymmetry is a decisive factor in how all kinds of relationships develop and how conflicts are handled and resolved.
Power makes the world go round. Power enables people to enforce their will over others and as such, it determines people’s attitude towards a conflict and the way they choose to resolve it. In this chapter, I will delineate the role of power in conflict management focusing on conflicts in organizations in particular. First, I will explain how power is defined and which are the main sources of power. Consequently, I will present research-based evidence on the role of power in conflict management. Finally, I will touch on the importance of distinguishing power that is construed by the power-holder as opportunity from power that is construed as responsibility.
Power is pervasive and as such, it is difficult to give it an accurate and clear-cut definition. For instance, power can be seen as the access to valuable material (food, money) or social (knowledge, information, decision-making opportunities) resources [1, 2], as the capability to achieve personal goals and influence other people’s outcomes, as the capability to administer punishments and rewards, or as the potential to influence others and modify their attitude and behavior [3].
Power may stem from various sources. For example, a senior manager may rely on their ability to punish or reward others to get things done. A renowned expert in a field may rely on their knowledge and expertise, and a person who is admired by others for their skills or achievements may rely on personal qualities to influence others.
Social psychologists John French and Bertram Raven [4] studied power more than half a century ago and suggested that power can arise from various sources. French and Raven have grouped the forms of power into two broad categories, namely
Finally,
Although positional power enables power-holders to get things done and ensure that everyone works towards the same goal, it is not the type of power that inspires people. It is personal power that wins the hearts and minds of people, inspires them, and prompts them to commit to tasks. In other words, personal power inspires people to rise to greater heights, set the bars high, and perform as well as possible. Personal power includes the following two types:
Finally,
Apart from the above sources of power, which stem from either one’s position or one’s personal qualities, people may possess a different type of power, the so-called
Source of power | Description and examples |
---|---|
People are influenced by the power-holder’s position rather than by the power-holder as a person. | |
People comply out of fear. | |
People comply in order to get rewarded. | |
People are actually influenced by the power-holder’s claims and change their attitude and behavior based on the power-holder’s attitude and behavior. | |
People “follow” (oftentimes uncritically) the power-holder no matter whether they agree with him/her or not. | |
People comply with the will of others more if they have no other attractive alternatives. |
Major sources of power.
Research suggests that besides their content-based differences, all kinds of power have a main characteristic in common: “dependence”. Regardless of the specific sources of power that are involved, it is the level of
To test this hypothesis, Van Kleef, De Dreu, Pietroni, and Manstead [10] conducted five studies. In Study 1, power was operationalized as one’s possession of an attractive alternative (BATNA). Participants were recruited in the lab and were assigned into one of the two experimental groups: high or low-power groups. All participants were assigned to the role of a phone seller and were told that two buyers were interested in the phones they were selling. The first buyer had already made an offer and participants had to negotiate the price with the second buyer. Participants in the high-power group were given an attractive offer (alternative) by the first buyer (the first buyer’s offer would give them 570 points, while the maximum points they could reach were 760 points). However, participants in the low-power group were given an unattractive offer (alternative) (the first buyer’s offer would only yield 190 points). Subsequently, participants had to negotiate the phone price with the second buyer and make a counteroffer. Importantly, participants got informed about the buyer’s (opponent) emotional reaction to their counteroffer. More specifically, buyers were presented as having reacted happily or angrily to the participants’ counteroffer. Results showed that low-power participants made more concessions than high-power participants, and also, the buyer’s emotions (angry or happy) influenced them to a greater extent. Specifically, low-power negotiators conceded more to an angry buyer than to a happy one, whereas high-power negotiators were immune to the buyer’s emotional state.
Van Kleef et al. [10] replicated these findings in four additional studies, where power was operationalized differently. For instance, in one study, high-power participants had a managerial position in an organization (legitimate power). In contrast, low-power participants had a junior-trainee position. In another study, high-power participants had the full support of the top management for the negotiation to come. In contrast, low-power participants did not (i.e., note that in conflicts in organizations), the availability of support increases individuals’ sense of power because it enables them to form coalitions with others in order to get their way and assures them that they do not stand alone in the conflict [11]. These findings suggest that regardless of the power source, the mere existence of power asymmetry between negotiators determines the negotiation outcome: The low-power negotiators are more likely to concede to their powerful opponent than the other way around. It is noteworthy, however, that in none of these studies did the researchers operationalize personal power. All five studies used positional power or BATNA to operationalize power and therefore, there is no evidence about how referent or expert power of power-holders influences an opponent’s reaction in the conflict.
An important reason for which power is such a determinant factor of conflict management is that power directs people’s willingness to search for information about their partner [12, 13]. Information gathering involves questioning one’s partner and “asking for information” to test one’s beliefs and assumptions [14, 15] and as such, it is central to conflict management. Importantly, questions can be diagnostic or leading. Diagnostic questions aim at providing evidence for or against one’s beliefs or assumptions, whereas leading questions have the purpose to yield answers that confirm one’s beliefs or assumptions, regardless of whether those beliefs and assumptions are valid or not [16]. Subsequently, diagnostic questions allow negotiators to better understand their partners and their wishes than leading questions [17, 18, 19]. In three experiments, De Dreu and Van Kleef [20] investigated the effects of power on people’s willingness to search for information about their negotiation partner. Participants were placed in a high or low-power position (relatively to their partners) and were also told that their partners had competitive or cooperative personalities. Just before negotiations began, participants were given the opportunity to write down questions they would like to ask their partners. Participants’ questions were then content-coded as diagnostic or leading.
In line with their predictions, De Dreu and Van Kleef [20] found that low-power participants indicated a stronger drive to understand their partner, which prompted them to ask more diagnostic than leading questions, especially when their partner was described as competitive. These findings provide evidence that low-power individuals, especially when faced with a competitive partner, feel less comfortable and are more likely to develop an accurate impression and opinion about their partner. However, high-power participants did not indicate such motivation regardless of their partner’s (competitive or cooperative) personality. These results might also shed light on why low-power negotiators are more influenced by powerful people’s emotions and why they concede more (as was shown by [10]).
Besides the differential outcomes that powerful and powerless individuals can achieve in conflicts and negotiations (e.g., more or less concessions of the opponent), power can also shape people’s emotional expression during a conflict. For instance, Petkanopoulou, Rodríguez-Bailón, Willis, & Van Kleef [21] carried out three studies to investigate how power shapes anger expression and what are the motives of high- versus low-power individuals to express anger at others. In line with their predictions, researchers found that high-power individuals are more prone to express their anger directly at their target as compared to low-power individuals, who are more likely to express their anger indirectly (e.g., by sharing it with other people rather than with the target of the anger). Moreover, low-power individuals expected that expressing their anger directly would elicit reciprocal anger in the powerful and would cause negative consequences to them. In contrast, high-power participants expected that both direct and indirect anger expressions would elicit fear rather than reciprocal anger in the powerless.
Based on the above, one would conclude that holding power, no matter what the source of power is, makes people appear tougher in conflict management processes, more immune to the others’ emotions, and more focused on self-interested goals. A fundamental question that arises here is: “Is power inherently “selfish”, and what is its functionality in organizations?” This is a very interesting question as power is inherent in organizations, in human interactions and relationships, and of course, in all kinds of conflict.
In real-life, we see that the effects of power on people’s behavior are not uniform. For instance, laypeople frequently rely on powerful others, seek advice, or count on their help whenever they need it. In the following, I present two contradictory functions of power in order to illuminate this issue: power as opportunity versus power as responsibility.
In the above, we defined and examined power as one’s capability to influence one’s outcomes, as one’s access to valuable material and social resources, as one’s capability to administer rewards or punishments to others, and as one’s potential to influence others. As such, power prompts power-holders to view their advantage over the powerless as an opportunity to achieve personal goals instead of taking care of the powerless. Indeed, power-holders frequently show less caring and affection towards the powerless and treat them as a means for goal attainment [22, 23]. The opportunistic propensity of power-holders is nicely depicted in the activation/inhibition system theory [2]. which suggests that possessing power frees people up from external constraints as power makes them feel that their resources approach or even exceed the demands of a situation. Therefore, power-holders have the luxury to experience situations predominantly as opportunities to achieve their own goals and therefore, construe others through a lens of self-interest [2]. In contrast, low power activates an “alarm system” that makes people experience situations and social interactions as a threat. Accordingly, low-power people are more sensitive to powerful others’ potential constraints and become more attentive to the interests, desires, and goals of the powerful. Subsequently, powerless people often become easier targets of power-holders’ aggression, dominance, and self-interested behavior [24, 25].
Based on the above, one would conclude that some paranoia about the powerful seems to be reasonable. There is evidence, however, that the effects of power are not uniform. In fact, we often observe that in real-life (e.g., within an organization) powerful people are more benevolent than they are thought to be, attentive to the others’ needs, and show concern about other people’s goals and interests [26, 27]. Indeed, rather than being careless or selfish, power-holders often see their power as responsibility towards others and as an inner obligation to take care of things that need to happen (e.g., ensuring that important goals are met [28]). For instance, we frequently see in organizations that leaders do show concern for their followers’ outcomes and use their power not only to serve their own goals but also the needs and desires of their followers [29, 30]. All in all, power, apart from giving power-holders the opportunity to act upon will and behave self-servingly, it also entails responsibility towards the powerless [29, 31].
A fundamental and interesting question is “when do power-holders see their power as responsibility or opportunity and how does the differential perception of power influence conflict management”? To the best of my knowledge, there is no empirical evidence to test this hypothesis directly. However, recent research shows that power-holders do not behave opportunistically when their power is stable and safe, that is when they do not fear that they might lose it. In contrast, when their power is unstable, power-holders are more susceptible to act self-servingly [32]. Indeed, prior research in the field of leadership suggests that when leaders are threatened by the prospect of losing power, which goes together with losing access to valuable resources, they react negatively to the prospective loss (see [33]). In a similar vein, research in the field of conflict management revealed that power-holders show more concern for their low-power partners’ needs when their power is not in jeopardy.
Fousiani et al. [34] conducted two studies to come to this conclusion. In the first study, participants were put in dyads and were told that they would negotiate some issues/disagreements with their partner. Participants were split into two groups: high and low-power groups. Participants in the high power group were assigned to the role of a powerful manager who had the ability to make decisions that affect employees. Participants in the low power group were assigned to the role of a powerless employee who had to follow the managers’ decisions. Most importantly, the issues or disagreements that participants were invited to negotiate with each other were not always the same. Dyads were invited to negotiate (in random order) power-related disagreements, that is disagreements about power possession in the decision-making processes, and task-related disagreements, that is disagreements regarding the coordination of work activities. Researchers found that high-power negotiators accommodated (gave in) their low power negotiating partner especially when the disagreements at hand touched on task-related but not power-related disagreements. According to the researchers’ interpretation, these findings point out power-holders’ motivation to accommodate the powerless when their powerful position was safe, and theis inclination to maintain the status quo and keep their power position intact [35, 36, 37]. In other words, high-power negotiators do not mind using their power in favor of the powerless and accommodating them as long as their power position is safe, but they do mind if their power position is in jeopardy.
Overall, these findings reveal that power-holders are not as opportunistic or competitive as they are believed to be. In fact, whether power-holders collaborate, accommodate or compete with the powerless in conflict situations seems to depend on how stable and safe their power is perceived to be. Based on the above, one would expect that power not only is it not inherently “selfish” but it is used responsibly and benevolently, especially when power-holders perceive their position as safe.
This chapter presented the impact of power on organizational conflict and conflict management in organizations based on the negotiation literature. Power is pervasive and as such, it has a great impact on conflicts in organizations. People usually associate power with unethicality and immorality, self-interested attitude and behavior, and win-lose outcomes [34, 38]. Indeed, empirical evidence supports this postulation and shows that power-holders are less empathic to the powerless and unaffected by their low-power partners’ emotions, less willing to search for the beliefs, needs, and desires of the powerless, and they always demand the larger piece of a pie.
However, we should be careful with overgeneralizing these findings as power is also associated with providing help and support to the powerless, taking care of things that others cannot take care of, and treating those in need with responsibility and benevolence. As such, power asymmetry in organizations is desirable and functional and may promote win-win outcomes for the involved members, especially when power-holders feel that their powerful position is safe and not subject to changes. This suggests that organizations should encourage interventions geared at fostering power-holders’ (e.g., leaders) sense of safety regarding their positions (see also, [39, 40]) in order to enable them to see their power as responsibility towards others rather than as opportunity and pay more attention to the needs and goals of the powerless (e.g., subordinate employees). Although power as responsibility is less attractive to power-holders and power as opportunity is particularly alluring [31], organizations might consider fostering the positive sides of being responsible for the outcomes and achievements of the powerless. This is the best way to ensure fairer outcomes and effective conflict management between those involved in asymmetric power relationships.
“The author declares no conflict of interest.”
Our books are published online and are accessible for free. However, if you are interested in ordering your hardcover copy, you can do so by contacting our Print Sales Department at orders@intechopen.com. All IntechOpen books are printed on demand in full-colour and delivered in signature packaging through free DHL Express delivery. A selection of our books in soft cover is also available through Amazon.
',metaTitle:"Order Print Copies",metaDescription:"Our books are published online and are accessible for free. However, if you are interested in ordering your printed copy, you can do so by contacting our Print Sales Department at orders@intechopen.com.\n\nOur hardcover books are carefully designed and printed on wood-free premium quality paper.\n\nThe paper size is 155 mm x 225 mm (6.1 X 8.8 inches).",metaKeywords:null,canonicalURL:"/page/order-print-copies",contentRaw:'[{"type":"htmlEditorComponent","content":"InTechOpen contributors can order print books at a special price ranging from:
\\n\\nFor a quote please contact us directly at orders@intechopen.com The quote will be sent to you within 1-2 business days.
\\n\\nAll of the books and chapters can be browsed online. To obtain InTechOpen's full book catalogue in PDF, please contact us.
\\n\\n\\n\\nIntechOpen works with award winning print-houses and we hold to the fact that all of our printed products are of the highest quality.
\\n\\nPrint copies of our publications are most often purchased as individual purchases by universities, libraries, institutions and academia personnel, hence increasing the visibility and outreach of our authors' published work among science communities and institutions. Our books are available at our direct Print Sales Department and through selected representatives throughout the world.
\\n\\nIndia - CBS Publishers & Distributors Pvt. Ltd.
\\n\\nASEAN - Books International
\\n\\nChina Publishers Services Ltd - CPS
\\n\\nMallory International Ltd
\\n\\nFor partnership opportunities, please contact orders@intechopen.com.
\\n\\n*The price does not include Value-Added Tax (VAT). Residents of European Union countries need to add a Book Value-Added Tax of 5%. Institutions and companies registered as VAT taxable entities in their own EU member state, will not pay VAT by providing us with their VAT registration number. This is made possible by the EU reverse charge method.
\\n"}]'},components:[{type:"htmlEditorComponent",content:'InTechOpen contributors can order print books at a special price ranging from:
\n\nFor a quote please contact us directly at orders@intechopen.com The quote will be sent to you within 1-2 business days.
\n\nAll of the books and chapters can be browsed online. To obtain InTechOpen's full book catalogue in PDF, please contact us.
\n\n\n\nIntechOpen works with award winning print-houses and we hold to the fact that all of our printed products are of the highest quality.
\n\nPrint copies of our publications are most often purchased as individual purchases by universities, libraries, institutions and academia personnel, hence increasing the visibility and outreach of our authors' published work among science communities and institutions. Our books are available at our direct Print Sales Department and through selected representatives throughout the world.
\n\nIndia - CBS Publishers & Distributors Pvt. Ltd.
\n\nASEAN - Books International
\n\nChina Publishers Services Ltd - CPS
\n\nMallory International Ltd
\n\nFor partnership opportunities, please contact orders@intechopen.com.
\n\n*The price does not include Value-Added Tax (VAT). Residents of European Union countries need to add a Book Value-Added Tax of 5%. Institutions and companies registered as VAT taxable entities in their own EU member state, will not pay VAT by providing us with their VAT registration number. This is made possible by the EU reverse charge method.
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"-totalCites"},profiles:[{id:"352625",title:"Dr.",name:"Nanjappa",middleName:null,surname:"Ashwath",slug:"nanjappa-ashwath",fullName:"Nanjappa Ashwath",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003633Y6QAI/Profile_Picture_1616134000897",biography:"Associate Professor Nanjappa Ashwath is a plant scientist researching on mine site rehabilitation and native species over the last 30 years. His speciality is in finding the right plant species to a degraded site to ensure that the established species will survive and provide long term ecosystem services. He has researched on restoring uranium mines, coal mines, metalliferous mines, mangrove habitats, roadside verges and railway embankments. He teaches into Australian Botany and Landscape Ecology & Management. Assoc Prof Ashwath supervises post graduate students on a range of topics, including phytoremediation, phytocapping and mine site restoration. His contribution to research at CQU has won him the Vice Chancellor’s Award for research. He has authored/co-authored over 200 publications and serves in the editorial committees of ~10 journals.",institutionString:null,institution:{name:"Central Queensland University",country:{name:"Australia"}}},{id:"131328",title:"Prof.",name:"Abdennasser",middleName:null,surname:"Chebira",slug:"abdennasser-chebira",fullName:"Abdennasser Chebira",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/131328/images/system/131328.jpg",biography:"Dr. Abdennasser Chebira received his Ph.D. degree in Electrical Engineering and Computer Sciences from PARIS XI University, Orsay, France, in 1994. Since September 1994 he works as Professor Assistant at Sénart Institute of Technology of PARIS XII – Val de Marne University. He is a staff researcher at Images, Signal and Intelligent Systems Laboratory (LISSI / EA 3956) of this University. His current research works concern selforganizing neural network based multi-modeling, hybrid neural based information processing systems; Neural based data fusion and complexity estimation.",institutionString:null,institution:null},{id:"262400",title:"Dr.",name:"Thiago Lopes",middleName:null,surname:"Rocha",slug:"thiago-lopes-rocha",fullName:"Thiago Lopes Rocha",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Goiás",country:{name:"Brazil"}}},{id:"327936",title:"Dr.",name:"Mohamed",middleName:null,surname:"Anli",slug:"mohamed-anli",fullName:"Mohamed Anli",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"512",title:"Dr.",name:"Dayang",middleName:null,surname:"Jawawi",slug:"dayang-jawawi",fullName:"Dayang Jawawi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Technology Malaysia",country:{name:"Malaysia"}}},{id:"197120",title:"Mr.",name:"Habib Ur",middleName:null,surname:"Rehman",slug:"habib-ur-rehman",fullName:"Habib Ur Rehman",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Agriculture Faisalabad",country:{name:"Pakistan"}}},{id:"328192",title:"Dr.",name:"Sameer",middleName:null,surname:"Kumar",slug:"sameer-kumar",fullName:"Sameer Kumar",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Central University of Kerala",country:{name:"India"}}},{id:"1024",title:"Dr.",name:"Keinosuke",middleName:null,surname:"Matsumoto",slug:"keinosuke-matsumoto",fullName:"Keinosuke Matsumoto",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Osaka Prefecture University",country:{name:"Japan"}}},{id:"66560",title:"Dr.",name:"Nicole",middleName:null,surname:"Verrills",slug:"nicole-verrills",fullName:"Nicole Verrills",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Newcastle Australia",country:{name:"Australia"}}},{id:"197632",title:"Ph.D.",name:"Karolína",middleName:null,surname:"Barinková",slug:"karolina-barinkova",fullName:"Karolína Barinková",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Pavol Jozef Šafárik",country:{name:"Slovakia"}}},{id:"328704",title:"Dr.",name:"Esther",middleName:null,surname:"Carrillo-Pérez",slug:"esther-carrillo-perez",fullName:"Esther Carrillo-Pérez",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidad de Sonora",country:{name:"Mexico"}}},{id:"66816",title:"Dr.",name:"Iwao",middleName:null,surname:"Emura",slug:"iwao-emura",fullName:"Iwao Emura",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Nagaoka Red Cross Hospital",country:{name:"Japan"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:13389},{group:"region",caption:"Middle and South America",value:2,count:11660},{group:"region",caption:"Africa",value:3,count:4168},{group:"region",caption:"Asia",value:4,count:22334},{group:"region",caption:"Australia and Oceania",value:5,count:2019},{group:"region",caption:"Europe",value:6,count:33642}],offset:12,limit:12,total:135275},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{topicId:"204"},books:[],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:27},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:7},{group:"topic",caption:"Business, Management and Economics",value:7,count:4},{group:"topic",caption:"Chemistry",value:8,count:16},{group:"topic",caption:"Computer and Information Science",value:9,count:18},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:8},{group:"topic",caption:"Engineering",value:11,count:42},{group:"topic",caption:"Environmental Sciences",value:12,count:5},{group:"topic",caption:"Immunology and Microbiology",value:13,count:8},{group:"topic",caption:"Materials Science",value:14,count:17},{group:"topic",caption:"Mathematics",value:15,count:9},{group:"topic",caption:"Medicine",value:16,count:68},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:3},{group:"topic",caption:"Neuroscience",value:18,count:3},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:7},{group:"topic",caption:"Physics",value:20,count:6},{group:"topic",caption:"Psychology",value:21,count:5},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:7},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:2}],offset:12,limit:12,total:0},popularBooks:{featuredBooks:[{type:"book",id:"7827",title:"Interpersonal Relationships",subtitle:null,isOpenForSubmission:!1,hash:"ebf41f4d17c75010eb3294cc8cac3d47",slug:"interpersonal-relationships",bookSignature:"Martha Peaslee Levine",coverURL:"https://cdn.intechopen.com/books/images_new/7827.jpg",editors:[{id:"186919",title:"Dr.",name:"Martha",middleName:null,surname:"Peaslee Levine",slug:"martha-peaslee-levine",fullName:"Martha Peaslee Levine"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10796",title:"Extracellular Vesicles",subtitle:"Role in Diseases, Pathogenesis and Therapy",isOpenForSubmission:!1,hash:"eb5407fcf93baff7bca3fae5640153a2",slug:"extracellular-vesicles-role-in-diseases-pathogenesis-and-therapy",bookSignature:"Manash K. Paul",coverURL:"https://cdn.intechopen.com/books/images_new/10796.jpg",editors:[{id:"319365",title:"Assistant Prof.",name:"Manash K.",middleName:null,surname:"Paul",slug:"manash-k.-paul",fullName:"Manash K. Paul"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10908",title:"Advances in Decision Making",subtitle:null,isOpenForSubmission:!1,hash:"126486f7f91e18e2e3539a32c38be7b1",slug:"advances-in-decision-making",bookSignature:"Fausto Pedro García Márquez",coverURL:"https://cdn.intechopen.com/books/images_new/10908.jpg",editors:[{id:"22844",title:"Prof.",name:"Fausto Pedro",middleName:null,surname:"García Márquez",slug:"fausto-pedro-garcia-marquez",fullName:"Fausto Pedro García Márquez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"95",title:"Applications and Experiences of Quality Control",subtitle:null,isOpenForSubmission:!1,hash:"4bcb22b1eee68210a977a97d5a0f363a",slug:"applications-and-experiences-of-quality-control",bookSignature:"Ognyan Ivanov",coverURL:"https://cdn.intechopen.com/books/images_new/95.jpg",editors:[{id:"22230",title:"Prof.",name:"Ognyan",middleName:null,surname:"Ivanov",slug:"ognyan-ivanov",fullName:"Ognyan Ivanov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"2160",title:"MATLAB",subtitle:"A Fundamental Tool for Scientific Computing and Engineering Applications - Volume 1",isOpenForSubmission:!1,hash:"dd9c658341fbd264ed4f8d9e6aa8ca29",slug:"matlab-a-fundamental-tool-for-scientific-computing-and-engineering-applications-volume-1",bookSignature:"Vasilios N. Katsikis",coverURL:"https://cdn.intechopen.com/books/images_new/2160.jpg",editors:[{id:"12289",title:"Prof.",name:"Vasilios",middleName:"N.",surname:"Katsikis",slug:"vasilios-katsikis",fullName:"Vasilios Katsikis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3560",title:"Advances in Landscape Architecture",subtitle:null,isOpenForSubmission:!1,hash:"a20614517ec5f7e91188fe8e42832138",slug:"advances-in-landscape-architecture",bookSignature:"Murat Özyavuz",coverURL:"https://cdn.intechopen.com/books/images_new/3560.jpg",editors:[{id:"93073",title:"Dr.",name:"Murat",middleName:null,surname:"Ozyavuz",slug:"murat-ozyavuz",fullName:"Murat Ozyavuz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10739",title:"Global Decline of Insects",subtitle:null,isOpenForSubmission:!1,hash:"543783652b9092962a8fa4bed38eeb17",slug:"global-decline-of-insects",bookSignature:"Hamadttu Abdel Farag El-Shafie",coverURL:"https://cdn.intechopen.com/books/images_new/10739.jpg",editors:[{id:"192142",title:"Dr.",name:"Hamadttu",middleName:null,surname:"Abdel Farag El-Shafie",slug:"hamadttu-abdel-farag-el-shafie",fullName:"Hamadttu Abdel Farag El-Shafie"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10911",title:"Higher Education",subtitle:"New Approaches to Accreditation, Digitalization, and Globalization in the Age of Covid",isOpenForSubmission:!1,hash:"223a02337498e535e967174c1f648fbc",slug:"higher-education-new-approaches-to-accreditation-digitalization-and-globalization-in-the-age-of-covid",bookSignature:"Lee Waller and Sharon Waller",coverURL:"https://cdn.intechopen.com/books/images_new/10911.jpg",editors:[{id:"263301",title:"Dr.",name:"Lee",middleName:null,surname:"Waller",slug:"lee-waller",fullName:"Lee Waller"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3568",title:"Recent Advances in Plant in vitro Culture",subtitle:null,isOpenForSubmission:!1,hash:"830bbb601742c85a3fb0eeafe1454c43",slug:"recent-advances-in-plant-in-vitro-culture",bookSignature:"Annarita Leva and Laura M. R. Rinaldi",coverURL:"https://cdn.intechopen.com/books/images_new/3568.jpg",editors:[{id:"142145",title:"Dr.",name:"Annarita",middleName:null,surname:"Leva",slug:"annarita-leva",fullName:"Annarita Leva"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3737",title:"MATLAB",subtitle:"Modelling, Programming and Simulations",isOpenForSubmission:!1,hash:null,slug:"matlab-modelling-programming-and-simulations",bookSignature:"Emilson Pereira Leite",coverURL:"https://cdn.intechopen.com/books/images_new/3737.jpg",editors:[{id:"12051",title:"Prof.",name:"Emilson",middleName:null,surname:"Pereira Leite",slug:"emilson-pereira-leite",fullName:"Emilson Pereira Leite"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"1770",title:"Gel Electrophoresis",subtitle:"Principles and Basics",isOpenForSubmission:!1,hash:"279701f6c802cf02deef45103e0611ff",slug:"gel-electrophoresis-principles-and-basics",bookSignature:"Sameh Magdeldin",coverURL:"https://cdn.intechopen.com/books/images_new/1770.jpg",editors:[{id:"123648",title:"Dr.",name:"Sameh",middleName:null,surname:"Magdeldin",slug:"sameh-magdeldin",fullName:"Sameh Magdeldin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:4798},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"7827",title:"Interpersonal Relationships",subtitle:null,isOpenForSubmission:!1,hash:"ebf41f4d17c75010eb3294cc8cac3d47",slug:"interpersonal-relationships",bookSignature:"Martha Peaslee Levine",coverURL:"https://cdn.intechopen.com/books/images_new/7827.jpg",publishedDate:"July 27th 2022",numberOfDownloads:7175,editors:[{id:"186919",title:"Dr.",name:"Martha",middleName:null,surname:"Peaslee Levine",slug:"martha-peaslee-levine",fullName:"Martha Peaslee Levine"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",publishedDate:"July 27th 2022",numberOfDownloads:1981,editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10796",title:"Extracellular Vesicles",subtitle:"Role in Diseases, Pathogenesis and Therapy",isOpenForSubmission:!1,hash:"eb5407fcf93baff7bca3fae5640153a2",slug:"extracellular-vesicles-role-in-diseases-pathogenesis-and-therapy",bookSignature:"Manash K. Paul",coverURL:"https://cdn.intechopen.com/books/images_new/10796.jpg",publishedDate:"July 20th 2022",numberOfDownloads:2308,editors:[{id:"319365",title:"Assistant Prof.",name:"Manash K.",middleName:null,surname:"Paul",slug:"manash-k.-paul",fullName:"Manash K. Paul"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10908",title:"Advances in Decision Making",subtitle:null,isOpenForSubmission:!1,hash:"126486f7f91e18e2e3539a32c38be7b1",slug:"advances-in-decision-making",bookSignature:"Fausto Pedro García Márquez",coverURL:"https://cdn.intechopen.com/books/images_new/10908.jpg",publishedDate:"July 27th 2022",numberOfDownloads:1473,editors:[{id:"22844",title:"Prof.",name:"Fausto Pedro",middleName:null,surname:"García Márquez",slug:"fausto-pedro-garcia-marquez",fullName:"Fausto Pedro García Márquez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"95",title:"Applications and Experiences of Quality Control",subtitle:null,isOpenForSubmission:!1,hash:"4bcb22b1eee68210a977a97d5a0f363a",slug:"applications-and-experiences-of-quality-control",bookSignature:"Ognyan Ivanov",coverURL:"https://cdn.intechopen.com/books/images_new/95.jpg",publishedDate:"April 26th 2011",numberOfDownloads:318571,editors:[{id:"22230",title:"Prof.",name:"Ognyan",middleName:null,surname:"Ivanov",slug:"ognyan-ivanov",fullName:"Ognyan Ivanov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"2160",title:"MATLAB",subtitle:"A Fundamental Tool for Scientific Computing and Engineering Applications - Volume 1",isOpenForSubmission:!1,hash:"dd9c658341fbd264ed4f8d9e6aa8ca29",slug:"matlab-a-fundamental-tool-for-scientific-computing-and-engineering-applications-volume-1",bookSignature:"Vasilios N. Katsikis",coverURL:"https://cdn.intechopen.com/books/images_new/2160.jpg",publishedDate:"September 26th 2012",numberOfDownloads:271836,editors:[{id:"12289",title:"Prof.",name:"Vasilios",middleName:"N.",surname:"Katsikis",slug:"vasilios-katsikis",fullName:"Vasilios Katsikis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3560",title:"Advances in Landscape Architecture",subtitle:null,isOpenForSubmission:!1,hash:"a20614517ec5f7e91188fe8e42832138",slug:"advances-in-landscape-architecture",bookSignature:"Murat Özyavuz",coverURL:"https://cdn.intechopen.com/books/images_new/3560.jpg",publishedDate:"July 1st 2013",numberOfDownloads:243450,editors:[{id:"93073",title:"Dr.",name:"Murat",middleName:null,surname:"Ozyavuz",slug:"murat-ozyavuz",fullName:"Murat Ozyavuz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10739",title:"Global Decline of Insects",subtitle:null,isOpenForSubmission:!1,hash:"543783652b9092962a8fa4bed38eeb17",slug:"global-decline-of-insects",bookSignature:"Hamadttu Abdel Farag El-Shafie",coverURL:"https://cdn.intechopen.com/books/images_new/10739.jpg",publishedDate:"July 20th 2022",numberOfDownloads:1582,editors:[{id:"192142",title:"Dr.",name:"Hamadttu",middleName:null,surname:"Abdel Farag El-Shafie",slug:"hamadttu-abdel-farag-el-shafie",fullName:"Hamadttu Abdel Farag El-Shafie"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10911",title:"Higher Education",subtitle:"New Approaches to Accreditation, Digitalization, and Globalization in the Age of Covid",isOpenForSubmission:!1,hash:"223a02337498e535e967174c1f648fbc",slug:"higher-education-new-approaches-to-accreditation-digitalization-and-globalization-in-the-age-of-covid",bookSignature:"Lee Waller and Sharon Waller",coverURL:"https://cdn.intechopen.com/books/images_new/10911.jpg",publishedDate:"July 13th 2022",numberOfDownloads:2082,editors:[{id:"263301",title:"Dr.",name:"Lee",middleName:null,surname:"Waller",slug:"lee-waller",fullName:"Lee Waller"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3568",title:"Recent Advances in Plant in vitro Culture",subtitle:null,isOpenForSubmission:!1,hash:"830bbb601742c85a3fb0eeafe1454c43",slug:"recent-advances-in-plant-in-vitro-culture",bookSignature:"Annarita Leva and Laura M. R. Rinaldi",coverURL:"https://cdn.intechopen.com/books/images_new/3568.jpg",publishedDate:"October 17th 2012",numberOfDownloads:256294,editors:[{id:"142145",title:"Dr.",name:"Annarita",middleName:null,surname:"Leva",slug:"annarita-leva",fullName:"Annarita Leva"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11328",title:"Botulinum Toxin",subtitle:"Recent Topics and Applications",isOpenForSubmission:!1,hash:"7dd05a316001cef143e209eda51387a7",slug:"botulinum-toxin-recent-topics-and-applications",bookSignature:"Suna Sabuncuoglu",coverURL:"https://cdn.intechopen.com/books/images_new/11328.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"270856",title:"Associate Prof.",name:"Suna",middleName:null,surname:"Sabuncuoglu",slug:"suna-sabuncuoglu",fullName:"Suna Sabuncuoglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11085",title:"Polycystic Ovary Syndrome",subtitle:"Functional Investigation and Clinical Application",isOpenForSubmission:!1,hash:"3066dd3ff29e1fac072fd60b08d4d3e7",slug:"polycystic-ovary-syndrome-functional-investigation-and-clinical-application",bookSignature:"Zhengchao Wang",coverURL:"https://cdn.intechopen.com/books/images_new/11085.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"204883",title:"Dr.",name:"Zhengchao",middleName:null,surname:"Wang",slug:"zhengchao-wang",fullName:"Zhengchao Wang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10833",title:"Tumor Angiogenesis and Modulators",subtitle:null,isOpenForSubmission:!1,hash:"f29b575c46128b2da061ef7f9bd1070b",slug:"tumor-angiogenesis-and-modulators",bookSignature:"Ke Xu",coverURL:"https://cdn.intechopen.com/books/images_new/10833.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"59529",title:"Dr.",name:"Ke",middleName:null,surname:"Xu",slug:"ke-xu",fullName:"Ke Xu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11356",title:"Molecular Cloning",subtitle:null,isOpenForSubmission:!1,hash:"671c629dd86e97f0fb467b9e70e92296",slug:"molecular-cloning",bookSignature:"Sadık Dincer, Hatice Aysun Mercimek Takcı and Melis Sumengen Ozdenef",coverURL:"https://cdn.intechopen.com/books/images_new/11356.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"188141",title:"Prof.",name:"Sadik",middleName:null,surname:"Dincer",slug:"sadik-dincer",fullName:"Sadik Dincer"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7827",title:"Interpersonal Relationships",subtitle:null,isOpenForSubmission:!1,hash:"ebf41f4d17c75010eb3294cc8cac3d47",slug:"interpersonal-relationships",bookSignature:"Martha Peaslee Levine",coverURL:"https://cdn.intechopen.com/books/images_new/7827.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"186919",title:"Dr.",name:"Martha",middleName:null,surname:"Peaslee Levine",slug:"martha-peaslee-levine",fullName:"Martha Peaslee Levine"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10908",title:"Advances in Decision Making",subtitle:null,isOpenForSubmission:!1,hash:"126486f7f91e18e2e3539a32c38be7b1",slug:"advances-in-decision-making",bookSignature:"Fausto Pedro García Márquez",coverURL:"https://cdn.intechopen.com/books/images_new/10908.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"22844",title:"Prof.",name:"Fausto Pedro",middleName:null,surname:"García Márquez",slug:"fausto-pedro-garcia-marquez",fullName:"Fausto Pedro García Márquez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10669",title:"Corrosion",subtitle:"Fundamentals and Protection Mechanisms",isOpenForSubmission:!1,hash:"4a76d54f8a40fc2e7002a8d13fd617c1",slug:"corrosion-fundamentals-and-protection-mechanisms",bookSignature:"Fahmina Zafar, Anujit Ghosal and Eram Sharmin",coverURL:"https://cdn.intechopen.com/books/images_new/10669.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"89672",title:"Dr.",name:"Fahmina",middleName:null,surname:"Zafar",slug:"fahmina-zafar",fullName:"Fahmina Zafar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10677",title:"Advanced Topics of Topology",subtitle:null,isOpenForSubmission:!1,hash:"bf964c52f9e653fac20a7fcab58070e5",slug:"advanced-topics-of-topology",bookSignature:"Francisco Bulnes",coverURL:"https://cdn.intechopen.com/books/images_new/10677.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"92918",title:"Dr.",name:"Francisco",middleName:null,surname:"Bulnes",slug:"francisco-bulnes",fullName:"Francisco Bulnes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11195",title:"Recent Advances in Biometrics",subtitle:null,isOpenForSubmission:!1,hash:"2d32e33e0f499cb5241734bb75dd2a83",slug:"recent-advances-in-biometrics",bookSignature:"Muhammad Sarfraz",coverURL:"https://cdn.intechopen.com/books/images_new/11195.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"215610",title:"Prof.",name:"Muhammad",middleName:null,surname:"Sarfraz",slug:"muhammad-sarfraz",fullName:"Muhammad Sarfraz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"191",title:"Ophthalmology",slug:"medicine-ophthalmology",parent:{id:"16",title:"Medicine",slug:"medicine"},numberOfBooks:41,numberOfSeries:0,numberOfAuthorsAndEditors:1044,numberOfWosCitations:414,numberOfCrossrefCitations:288,numberOfDimensionsCitations:667,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"191",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"10879",title:"Vision Correction and Eye Surgery",subtitle:null,isOpenForSubmission:!1,hash:"4cead9a92f73922e325d7d2a3a94e321",slug:"vision-correction-and-eye-surgery",bookSignature:"Giuseppe Lo Giudice",coverURL:"https://cdn.intechopen.com/books/images_new/10879.jpg",editedByType:"Edited by",editors:[{id:"87607",title:"M.D.",name:"Giuseppe",middleName:null,surname:"Lo Giudice",slug:"giuseppe-lo-giudice",fullName:"Giuseppe Lo Giudice"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11039",title:"Diabetic Eye Disease",subtitle:"From Therapeutic Pipeline to the Real World",isOpenForSubmission:!1,hash:"22986eb45c0b2692661bc8f8804045d0",slug:"diabetic-eye-disease-from-therapeutic-pipeline-to-the-real-world",bookSignature:"Giuseppe Lo Giudice",coverURL:"https://cdn.intechopen.com/books/images_new/11039.jpg",editedByType:"Edited by",editors:[{id:"87607",title:"M.D.",name:"Giuseppe",middleName:null,surname:"Lo Giudice",slug:"giuseppe-lo-giudice",fullName:"Giuseppe Lo Giudice"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10732",title:"Dry Eye Syndrome",subtitle:"Modern Diagnostic Techniques and Advanced Treatments",isOpenForSubmission:!1,hash:"44a1939cac17b7cfebbef5e156af0b2a",slug:"dry-eye-syndrome-modern-diagnostic-techniques-and-advanced-treatments",bookSignature:"Felicia M. Ferreri",coverURL:"https://cdn.intechopen.com/books/images_new/10732.jpg",editedByType:"Edited by",editors:[{id:"32442",title:"Prof.",name:"Felicia M.",middleName:null,surname:"Ferreri",slug:"felicia-m.-ferreri",fullName:"Felicia M. Ferreri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10345",title:"Infectious Eye Diseases",subtitle:"Recent Advances in Diagnosis and Treatment",isOpenForSubmission:!1,hash:"1d2abb832f0773c90fc9a12d1a41194c",slug:"infectious-eye-diseases-recent-advances-in-diagnosis-and-treatment",bookSignature:"Alejandro Rodriguez-Garcia and Julio C. Hernandez-Camarena",coverURL:"https://cdn.intechopen.com/books/images_new/10345.jpg",editedByType:"Edited by",editors:[{id:"209514",title:"Dr.",name:"Alejandro",middleName:null,surname:"Rodriguez-Garcia",slug:"alejandro-rodriguez-garcia",fullName:"Alejandro Rodriguez-Garcia"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10343",title:"Ocular Hypertension",subtitle:"The Knowns and Unknowns",isOpenForSubmission:!1,hash:"0ff71cc7e0d9f394f41162c0c825588a",slug:"ocular-hypertension-the-knowns-and-unknowns",bookSignature:"Michele Lanza",coverURL:"https://cdn.intechopen.com/books/images_new/10343.jpg",editedByType:"Edited by",editors:[{id:"240088",title:"Prof.",name:"Michele",middleName:null,surname:"Lanza",slug:"michele-lanza",fullName:"Michele Lanza"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10293",title:"Eyesight and Imaging",subtitle:"Advances and New Perspectives",isOpenForSubmission:!1,hash:"2c4e3e515bebe6053f3f1f57e4854462",slug:"eyesight-and-imaging-advances-and-new-perspectives",bookSignature:"Alireza Ziaei and Michele Lanza",coverURL:"https://cdn.intechopen.com/books/images_new/10293.jpg",editedByType:"Edited by",editors:[{id:"271630",title:"Dr.",name:"Alireza",middleName:null,surname:"Ziaei",slug:"alireza-ziaei",fullName:"Alireza Ziaei"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10534",title:"Current Cataract Surgical Techniques",subtitle:null,isOpenForSubmission:!1,hash:"7b3bfcd2c690d037d693f31545a36fda",slug:"current-cataract-surgical-techniques",bookSignature:"Xiaogang Wang",coverURL:"https://cdn.intechopen.com/books/images_new/10534.jpg",editedByType:"Edited by",editors:[{id:"243698",title:"Dr.",name:"Xiaogang",middleName:null,surname:"Wang",slug:"xiaogang-wang",fullName:"Xiaogang Wang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7703",title:"Ocular Surface Diseases",subtitle:"Some Current Date on Tear Film Problem and Keratoconic Diagnosis",isOpenForSubmission:!1,hash:"3dcf967eb2f185930ce7fb7ae462d4e0",slug:"ocular-surface-diseases-some-current-date-on-tear-film-problem-and-keratoconic-diagnosis",bookSignature:"Dorota Kopacz",coverURL:"https://cdn.intechopen.com/books/images_new/7703.jpg",editedByType:"Edited by",editors:[{id:"271261",title:"Dr.",name:"Dorota",middleName:null,surname:"Kopacz",slug:"dorota-kopacz",fullName:"Dorota Kopacz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7176",title:"Visual Impairment and Blindness",subtitle:"What We Know and What We Have to Know",isOpenForSubmission:!1,hash:"6b1848a23af744fba1f0eef95fb4b2d1",slug:"visual-impairment-and-blindness-what-we-know-and-what-we-have-to-know",bookSignature:"Giuseppe Lo Giudice and Angel Catalá",coverURL:"https://cdn.intechopen.com/books/images_new/7176.jpg",editedByType:"Edited by",editors:[{id:"87607",title:"M.D.",name:"Giuseppe",middleName:null,surname:"Lo Giudice",slug:"giuseppe-lo-giudice",fullName:"Giuseppe Lo Giudice"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8855",title:"Retinoblastoma",subtitle:"Past, Present and Future",isOpenForSubmission:!1,hash:"1686b2f1d697de9d4bc2005a5fa9b998",slug:"retinoblastoma-past-present-and-future",bookSignature:"Hind Manaa Alkatan",coverURL:"https://cdn.intechopen.com/books/images_new/8855.jpg",editedByType:"Edited by",editors:[{id:"223782",title:"Dr.",name:"Hind",middleName:"Manaa",surname:"Alkatan",slug:"hind-alkatan",fullName:"Hind Alkatan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7858",title:"A Practical Guide to Clinical Application of OCT in Ophthalmology",subtitle:null,isOpenForSubmission:!1,hash:"8e2d479cc9258dee430f8ba4c353c468",slug:"a-practical-guide-to-clinical-application-of-oct-in-ophthalmology",bookSignature:"Michele Lanza",coverURL:"https://cdn.intechopen.com/books/images_new/7858.jpg",editedByType:"Edited by",editors:[{id:"240088",title:"Prof.",name:"Michele",middleName:null,surname:"Lanza",slug:"michele-lanza",fullName:"Michele Lanza"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8633",title:"Novel Diagnostic Methods in Ophthalmology",subtitle:null,isOpenForSubmission:!1,hash:"da2c90e8db647ead30504defce3fb5d3",slug:"novel-diagnostic-methods-in-ophthalmology",bookSignature:"Anna Nowinska",coverURL:"https://cdn.intechopen.com/books/images_new/8633.jpg",editedByType:"Edited by",editors:[{id:"261466",title:"Dr.",name:"Anna",middleName:"Karolina",surname:"Nowińska",slug:"anna-nowinska",fullName:"Anna Nowińska"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:41,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"23828",doi:"10.5772/18498",title:"Glaucoma Animal Models",slug:"glaucoma-animal-models",totalDownloads:2914,totalCrossrefCites:10,totalDimensionsCites:18,abstract:null,book:{id:"268",slug:"glaucoma-basic-and-clinical-concepts",title:"Glaucoma",fullTitle:"Glaucoma - Basic and Clinical Concepts"},signatures:"Elena Vecino and Sansar C. Sharma",authors:[{id:"31685",title:"Prof.",name:"Elena",middleName:null,surname:"Vecino",slug:"elena-vecino",fullName:"Elena Vecino"},{id:"36188",title:"Prof.",name:"Sansar",middleName:null,surname:"Sharma",slug:"sansar-sharma",fullName:"Sansar Sharma"}]},{id:"29195",doi:"10.5772/30302",title:"Optical Coherence Tomography Findings in Diabetic Macular Edema",slug:"optical-coherence-tomography-findings-in-diabetic-macular-edema",totalDownloads:7272,totalCrossrefCites:7,totalDimensionsCites:13,abstract:null,book:{id:"666",slug:"diabetic-retinopathy",title:"Diabetic Retinopathy",fullTitle:"Diabetic Retinopathy"},signatures:"Desislava Koleva-Georgieva",authors:[{id:"81842",title:"Dr.",name:"Desislava",middleName:null,surname:"Koleva-Georgieva",slug:"desislava-koleva-georgieva",fullName:"Desislava Koleva-Georgieva"}]},{id:"23814",doi:"10.5772/26559",title:"Mechanism of Aqueous Humor Secretion, Its Regulation and Relevance to Glaucoma",slug:"mechanism-of-aqueous-humor-secretion-its-regulation-and-relevance-to-glaucoma",totalDownloads:13552,totalCrossrefCites:9,totalDimensionsCites:13,abstract:null,book:{id:"268",slug:"glaucoma-basic-and-clinical-concepts",title:"Glaucoma",fullTitle:"Glaucoma - Basic and Clinical Concepts"},signatures:"Mohammad Shahidullah, Waleed Hassan Al-Malki and Nicholas A. Delamere",authors:[{id:"67082",title:"Dr.",name:"Mohammad",middleName:null,surname:"Shahidullah",slug:"mohammad-shahidullah",fullName:"Mohammad Shahidullah"},{id:"140321",title:"Prof.",name:"Waleed Hassan",middleName:null,surname:"Al-Malki",slug:"waleed-hassan-al-malki",fullName:"Waleed Hassan Al-Malki"},{id:"140322",title:"Prof.",name:"Nicholas",middleName:null,surname:"Delamere",slug:"nicholas-delamere",fullName:"Nicholas Delamere"}]},{id:"39271",doi:"10.5772/48436",title:"Hydrogel Contact Lenses Surface Roughness and Bacterial Adhesion",slug:"hydrogel-contact-lenses-surface-roughness-and-bacterial-adhesion",totalDownloads:3923,totalCrossrefCites:2,totalDimensionsCites:13,abstract:null,book:{id:"1203",slug:"ocular-diseases",title:"Ocular Diseases",fullTitle:"Ocular Diseases"},signatures:"Maria Jesus Giraldez and Eva Yebra-Pimentel",authors:[{id:"143929",title:"PhD.",name:"Maria Jesus",middleName:null,surname:"Giraldez",slug:"maria-jesus-giraldez",fullName:"Maria Jesus Giraldez"},{id:"145699",title:"Prof.",name:"Eva",middleName:null,surname:"Yebra-Pimentel",slug:"eva-yebra-pimentel",fullName:"Eva Yebra-Pimentel"}]},{id:"17273",doi:"10.5772/21747",title:"ERG in Drosophila",slug:"erg-in-drosophila",totalDownloads:4947,totalCrossrefCites:8,totalDimensionsCites:13,abstract:null,book:{id:"360",slug:"electroretinograms",title:"Electroretinograms",fullTitle:"Electroretinograms"},signatures:"Gregor Belusic",authors:[{id:"44595",title:"Dr.",name:"Gregor",middleName:null,surname:"Belusic",slug:"gregor-belusic",fullName:"Gregor Belusic"}]}],mostDownloadedChaptersLast30Days:[{id:"18955",title:"The Optic Nerve in Glaucoma",slug:"the-optic-nerve-in-glaucoma",totalDownloads:17833,totalCrossrefCites:1,totalDimensionsCites:4,abstract:null,book:{id:"517",slug:"the-mystery-of-glaucoma",title:"The Mystery of Glaucoma",fullTitle:"The Mystery of Glaucoma"},signatures:"Ivan Marjanovic",authors:[{id:"36284",title:"Ph.D.",name:"Ivan",middleName:null,surname:"Marjanovic",slug:"ivan-marjanovic",fullName:"Ivan Marjanovic"}]},{id:"66120",title:"Binocular Functions",slug:"binocular-functions",totalDownloads:1886,totalCrossrefCites:0,totalDimensionsCites:0,abstract:"Binocular single vision is the ability to use both eyes simultaneously so that each eye contributes to a common single perception. Normal binocular single vision occurs with bifoveal fixation and normal retinal correspondence in everyday sight. There are various anatomical and physiological factors concerned in the development of Binocular vision. The development of binocular function starts at 6 weeks and is completed by 6 months. Any obstacles, sensory, motor, or central, in the flex pathway is likely to hamper the development of binocular vision. The presence of these obstacles gives rise to various sensory adaptations to binocular dysfunction. Clinically the tests used can be based on either of the two principles: (A) assessment of relationship between the fovea of the fixing eye and the retinal area stimulated in the squinting eye, viz. Bagolini striated glasses test, red filter test, synoptophore using SMP slides for measuring the objective and subjective angles, and Worth 4-dot test; and (B) Assessment of the visual directions of the two foveae, viz. after image test (Hering Bielschowsky); and Cuppers binocular visuoscopy test (foveo-foveal test of Cuppers). Anomalies of binocular vision results in confusion, diplopia, which leads to suppression, eccentric fixation, anomalous retinal correspondence, and amblyopia.",book:{id:"8418",slug:"eye-motility",title:"Eye Motility",fullTitle:"Eye Motility"},signatures:"Arvind Kumar Morya, Kanchan Solanki, Sahil Bhandari and Anushree Naidu",authors:[{id:"270083",title:"Prof.",name:"Arvind",middleName:null,surname:"Morya",slug:"arvind-morya",fullName:"Arvind Morya"},{id:"273705",title:"Dr.",name:"Kalpit",middleName:null,surname:"Jangid",slug:"kalpit-jangid",fullName:"Kalpit Jangid"},{id:"279906",title:"Dr.",name:"Kanchan",middleName:null,surname:"Solanki",slug:"kanchan-solanki",fullName:"Kanchan Solanki"},{id:"279907",title:"Dr.",name:"Sahil",middleName:null,surname:"Bhandari",slug:"sahil-bhandari",fullName:"Sahil Bhandari"},{id:"290171",title:"Dr.",name:"Anushree",middleName:null,surname:"Naidu",slug:"anushree-naidu",fullName:"Anushree Naidu"},{id:"290172",title:"Dr.",name:"Priyanka",middleName:null,surname:"Rathore",slug:"priyanka-rathore",fullName:"Priyanka Rathore"},{id:"290173",title:"Dr.",name:"Sujeet",middleName:null,surname:"Prakash",slug:"sujeet-prakash",fullName:"Sujeet Prakash"},{id:"290174",title:"Dr.",name:"Sonalika",middleName:null,surname:"Gogia",slug:"sonalika-gogia",fullName:"Sonalika Gogia"},{id:"290176",title:"Dr.",name:"Sulabh",middleName:null,surname:"Sahu",slug:"sulabh-sahu",fullName:"Sulabh Sahu"}]},{id:"46503",title:"Disorders of Optic Nerve and Visual Pathways",slug:"disorders-of-optic-nerve-and-visual-pathways",totalDownloads:3930,totalCrossrefCites:1,totalDimensionsCites:1,abstract:null,book:{id:"3848",slug:"ophthalmology-current-clinical-and-research-updates",title:"Ophthalmology",fullTitle:"Ophthalmology - Current Clinical and Research Updates"},signatures:"Ipek Midi",authors:[{id:"169657",title:"Dr.",name:"Ipek",middleName:null,surname:"Midi",slug:"ipek-midi",fullName:"Ipek Midi"}]},{id:"18960",title:"Measurement of Anterior Chamber Angle with Optical Coherence Tomography",slug:"measurement-of-anterior-chamber-angle-with-optical-coherence-tomography",totalDownloads:6215,totalCrossrefCites:0,totalDimensionsCites:1,abstract:null,book:{id:"517",slug:"the-mystery-of-glaucoma",title:"The Mystery of Glaucoma",fullTitle:"The Mystery of Glaucoma"},signatures:"De Orta-Arellano F, Muñoz-Rodriguez P and Salinas-Gallegos JL",authors:[{id:"31619",title:"Dr.",name:"Fabiola",middleName:null,surname:"de Orta Arellano",slug:"fabiola-de-orta-arellano",fullName:"Fabiola de Orta Arellano"},{id:"35207",title:"Dr.",name:"Pablo",middleName:null,surname:"Muñoz Rodriguez",slug:"pablo-munoz-rodriguez",fullName:"Pablo Muñoz Rodriguez"},{id:"35208",title:"Dr.",name:"José Luis",middleName:null,surname:"Salinas Gallegos",slug:"jose-luis-salinas-gallegos",fullName:"José Luis Salinas Gallegos"}]},{id:"42721",title:"Intracameral Mydriatics in Cataract Surgery",slug:"intracameral-mydriatics-in-cataract-surgery",totalDownloads:8517,totalCrossrefCites:0,totalDimensionsCites:3,abstract:null,book:{id:"239",slug:"cataract-surgery",title:"Cataract Surgery",fullTitle:"Cataract Surgery"},signatures:"Anders Behndig, Björn Lundberg and Gunnie Bäckström",authors:[{id:"47264",title:"Prof.",name:"Anders",middleName:null,surname:"Behndig",slug:"anders-behndig",fullName:"Anders Behndig"},{id:"53862",title:"Mr.",name:"Björn",middleName:null,surname:"Lundberg",slug:"bjorn-lundberg",fullName:"Björn Lundberg"},{id:"53863",title:"Mrs.",name:"Gunni",middleName:null,surname:"Bäckström",slug:"gunni-backstrom",fullName:"Gunni Bäckström"}]}],onlineFirstChaptersFilter:{topicId:"191",limit:6,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:8,limit:8,total:0},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:9,numberOfPublishedChapters:90,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:107,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:33,numberOfPublishedChapters:330,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:14,numberOfPublishedChapters:145,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:9,numberOfPublishedChapters:139,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:122,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:112,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:21,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:10,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:"2753-6580",doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}},{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}}]},series:{item:{id:"6",title:"Infectious Diseases",doi:"10.5772/intechopen.71852",issn:"2631-6188",scope:"This series will provide a comprehensive overview of recent research trends in various Infectious Diseases (as per the most recent Baltimore classification). Topics will include general overviews of infections, immunopathology, diagnosis, treatment, epidemiology, etiology, and current clinical recommendations for managing infectious diseases. Ongoing issues, recent advances, and future diagnostic approaches and therapeutic strategies will also be discussed. This book series will focus on various aspects and properties of infectious diseases whose deep understanding is essential for safeguarding the human race from losing resources and economies due to pathogens.",coverUrl:"https://cdn.intechopen.com/series/covers/6.jpg",latestPublicationDate:"August 2nd, 2022",hasOnlineFirst:!0,numberOfPublishedBooks:13,editor:{id:"131400",title:"Prof.",name:"Alfonso J.",middleName:null,surname:"Rodriguez-Morales",slug:"alfonso-j.-rodriguez-morales",fullName:"Alfonso J. Rodriguez-Morales",profilePictureURL:"https://mts.intechopen.com/storage/users/131400/images/system/131400.png",biography:"Dr. Rodriguez-Morales is an expert in tropical and emerging diseases, particularly zoonotic and vector-borne diseases (especially arboviral diseases). He is the president of the Travel Medicine Committee of the Pan-American Infectious Diseases Association (API), as well as the president of the Colombian Association of Infectious Diseases (ACIN). He is a member of the Committee on Tropical Medicine, Zoonoses, and Travel Medicine of ACIN. He is a vice-president of the Latin American Society for Travel Medicine (SLAMVI) and a Member of the Council of the International Society for Infectious Diseases (ISID). Since 2014, he has been recognized as a Senior Researcher, at the Ministry of Science of Colombia. He is a professor at the Faculty of Medicine of the Fundacion Universitaria Autonoma de las Americas, in Pereira, Risaralda, Colombia. He is an External Professor, Master in Research on Tropical Medicine and International Health, Universitat de Barcelona, Spain. He is also a professor at the Master in Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru. In 2021 he has been awarded the “Raul Isturiz Award” Medal of the API. Also, in 2021, he was awarded with the “Jose Felix Patiño” Asclepius Staff Medal of the Colombian Medical College, due to his scientific contributions to COVID-19 during the pandemic. He is currently the Editor in Chief of the journal Travel Medicine and Infectious Diseases. His Scopus H index is 47 (Google Scholar H index, 68).",institutionString:"Institución Universitaria Visión de las Américas, Colombia",institution:null},editorTwo:null,editorThree:null},subseries:{paginationCount:4,paginationItems:[{id:"3",title:"Bacterial Infectious Diseases",coverUrl:"https://cdn.intechopen.com/series_topics/covers/3.jpg",isOpenForSubmission:!0,editor:{id:"205604",title:"Dr.",name:"Tomas",middleName:null,surname:"Jarzembowski",slug:"tomas-jarzembowski",fullName:"Tomas Jarzembowski",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRKriQAG/Profile_Picture_2022-06-16T11:01:31.jpg",biography:"Tomasz Jarzembowski was born in 1968 in Gdansk, Poland. He obtained his Ph.D. degree in 2000 from the Medical University of Gdańsk (UG). After specialization in clinical microbiology in 2003, he started studying biofilm formation and antibiotic resistance at the single-cell level. In 2015, he obtained his D.Sc. degree. His later study in cooperation with experts in nephrology and immunology resulted in the designation of the new diagnostic method of UTI, patented in 2017. He is currently working at the Department of Microbiology, Medical University of Gdańsk (GUMed), Poland. Since many years, he is a member of steering committee of Gdańsk branch of Polish Society of Microbiologists, a member of ESCMID. He is also a reviewer and a member of editorial boards of a number of international journals.",institutionString:"Medical University of Gdańsk, Poland",institution:null},editorTwo:{id:"484980",title:"Dr.",name:"Katarzyna",middleName:null,surname:"Garbacz",slug:"katarzyna-garbacz",fullName:"Katarzyna Garbacz",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003St8TAQAZ/Profile_Picture_2022-07-07T09:45:16.jpg",biography:"Katarzyna Maria Garbacz, MD, is an Associate Professor at the Medical University of Gdańsk, Poland and she is head of the Department of Oral Microbiology of the Medical University of Gdańsk. She has published more than 50 scientific publications in peer-reviewed journals. She has been a project leader funded by the National Science Centre of Poland. Prof. Garbacz is a microbiologist working on applied and fundamental questions in microbial epidemiology and pathogenesis. Her research interest is in antibiotic resistance, host-pathogen interaction, and therapeutics development for staphylococcal pathogens, mainly Staphylococcus aureus, which causes hospital-acquired infections. Currently, her research is mostly focused on the study of oral pathogens, particularly Staphylococcus spp.",institutionString:"Medical University of Gdańsk, Poland",institution:null},editorThree:null},{id:"4",title:"Fungal Infectious Diseases",coverUrl:"https://cdn.intechopen.com/series_topics/covers/4.jpg",isOpenForSubmission:!0,editor:{id:"174134",title:"Dr.",name:"Yuping",middleName:null,surname:"Ran",slug:"yuping-ran",fullName:"Yuping Ran",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bS9d6QAC/Profile_Picture_1630330675373",biography:"Dr. Yuping Ran, Professor, Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China. Completed the Course Medical Mycology, the Centraalbureau voor Schimmelcultures (CBS), Fungal Biodiversity Centre, Netherlands (2006). International Union of Microbiological Societies (IUMS) Fellow, and International Emerging Infectious Diseases (IEID) Fellow, Centers for Diseases Control and Prevention (CDC), Atlanta, USA. Diploma of Dermatological Scientist, Japanese Society for Investigative Dermatology. Ph.D. of Juntendo University, Japan. Bachelor’s and Master’s degree, Medicine, West China University of Medical Sciences. Chair of Sichuan Medical Association Dermatology Committee. General Secretary of The 19th Annual Meeting of Chinese Society of Dermatology and the Asia Pacific Society for Medical Mycology (2013). In charge of the Annual Medical Mycology Course over 20-years authorized by National Continue Medical Education Committee of China. Member of the board of directors of the Asia-Pacific Society for Medical Mycology (APSMM). Associate editor of Mycopathologia. Vice-chief of the editorial board of Chinses Journal of Mycology, China. Board Member and Chair of Mycology Group of Chinese Society of Dermatology.",institutionString:null,institution:{name:"Sichuan University",institutionURL:null,country:{name:"China"}}},editorTwo:null,editorThree:null},{id:"5",title:"Parasitic Infectious Diseases",coverUrl:"https://cdn.intechopen.com/series_topics/covers/5.jpg",isOpenForSubmission:!0,editor:{id:"67907",title:"Dr.",name:"Amidou",middleName:null,surname:"Samie",slug:"amidou-samie",fullName:"Amidou Samie",profilePictureURL:"https://mts.intechopen.com/storage/users/67907/images/system/67907.jpg",biography:"Dr. Amidou Samie is an Associate Professor of Microbiology at the University of Venda, in South Africa, where he graduated for his PhD in May 2008. He joined the Department of Microbiology the same year and has been giving lectures on topics covering parasitology, immunology, molecular biology and industrial microbiology. He is currently a rated researcher by the National Research Foundation of South Africa at category C2. He has published widely in the field of infectious diseases and has overseen several MSc’s and PhDs. His research activities mostly cover topics on infectious diseases from epidemiology to control. His particular interest lies in the study of intestinal protozoan parasites and opportunistic infections among HIV patients as well as the potential impact of childhood diarrhoea on growth and child development. He also conducts research on water-borne diseases and water quality and is involved in the evaluation of point-of-use water treatment technologies using silver and copper nanoparticles in collaboration with the University of Virginia, USA. He also studies the use of medicinal plants for the control of infectious diseases as well as antimicrobial drug resistance.",institutionString:null,institution:{name:"University of Venda",institutionURL:null,country:{name:"South Africa"}}},editorTwo:null,editorThree:null},{id:"6",title:"Viral Infectious Diseases",coverUrl:"https://cdn.intechopen.com/series_topics/covers/6.jpg",isOpenForSubmission:!0,editor:{id:"158026",title:"Prof.",name:"Shailendra K.",middleName:null,surname:"Saxena",slug:"shailendra-k.-saxena",fullName:"Shailendra K. Saxena",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRET3QAO/Profile_Picture_2022-05-10T10:10:26.jpeg",biography:"Professor Dr. Shailendra K. Saxena is a vice dean and professor at King George's Medical University, Lucknow, India. His research interests involve understanding the molecular mechanisms of host defense during human viral infections and developing new predictive, preventive, and therapeutic strategies for them using Japanese encephalitis virus (JEV), HIV, and emerging viruses as a model via stem cell and cell culture technologies. His research work has been published in various high-impact factor journals (Science, PNAS, Nature Medicine) with a high number of citations. He has received many awards and honors in India and abroad including various Young Scientist Awards, BBSRC India Partnering Award, and Dr. JC Bose National Award of Department of Biotechnology, Min. of Science and Technology, Govt. of India. Dr. Saxena is a fellow of various international societies/academies including the Royal College of Pathologists, United Kingdom; Royal Society of Medicine, London; Royal Society of Biology, United Kingdom; Royal Society of Chemistry, London; and Academy of Translational Medicine Professionals, Austria. He was named a Global Leader in Science by The Scientist. He is also an international opinion leader/expert in vaccination for Japanese encephalitis by IPIC (UK).",institutionString:"King George's Medical University",institution:{name:"King George's Medical University",institutionURL:null,country:{name:"India"}}},editorTwo:null,editorThree:null}]},overviewPageOFChapters:{paginationCount:19,paginationItems:[{id:"82804",title:"Psychiatric Problems in HIV Care",doi:"10.5772/intechopen.106077",signatures:"Seggane Musisi and Noeline Nakasujja",slug:"psychiatric-problems-in-hiv-care",totalDownloads:1,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Future Opportunities and Tools for Emerging Challenges for HIV/AIDS Control",coverURL:"https://cdn.intechopen.com/books/images_new/11575.jpg",subseries:{id:"6",title:"Viral Infectious Diseases"}}},{id:"82827",title:"Epidemiology and Control of Schistosomiasis",doi:"10.5772/intechopen.105170",signatures:"Célestin Kyambikwa Bisangamo",slug:"epidemiology-and-control-of-schistosomiasis",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"New Horizons for Schistosomiasis Research",coverURL:"https://cdn.intechopen.com/books/images_new/10829.jpg",subseries:{id:"5",title:"Parasitic Infectious Diseases"}}},{id:"82817",title:"Perspective Chapter: Microfluidic Technologies for On-Site Detection and Quantification of Infectious Diseases - The Experience with SARS-CoV-2/COVID-19",doi:"10.5772/intechopen.105950",signatures:"Andres Escobar and Chang-qing Xu",slug:"perspective-chapter-microfluidic-technologies-for-on-site-detection-and-quantification-of-infectious",totalDownloads:3,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"SARS-CoV-2 Variants - Two Years After",coverURL:"https://cdn.intechopen.com/books/images_new/11573.jpg",subseries:{id:"6",title:"Viral Infectious Diseases"}}},{id:"82667",title:"Perspective Chapter: Analysis of SARS-CoV-2 Indirect Spreading Routes and Possible Countermeasures",doi:"10.5772/intechopen.105914",signatures:"Cesare Saccani, Marco Pellegrini and Alessandro Guzzini",slug:"perspective-chapter-analysis-of-sars-cov-2-indirect-spreading-routes-and-possible-countermeasures",totalDownloads:10,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"SARS-CoV-2 Variants - Two Years After",coverURL:"https://cdn.intechopen.com/books/images_new/11573.jpg",subseries:{id:"6",title:"Viral Infectious Diseases"}}}]},overviewPagePublishedBooks:{paginationCount:13,paginationItems:[{type:"book",id:"6667",title:"Influenza",subtitle:"Therapeutics and Challenges",coverURL:"https://cdn.intechopen.com/books/images_new/6667.jpg",slug:"influenza-therapeutics-and-challenges",publishedDate:"September 19th 2018",editedByType:"Edited by",bookSignature:"Shailendra K. Saxena",hash:"105e347b2d5dbbe6b593aceffa051efa",volumeInSeries:1,fullTitle:"Influenza - Therapeutics and Challenges",editors:[{id:"158026",title:"Prof.",name:"Shailendra K.",middleName:null,surname:"Saxena",slug:"shailendra-k.-saxena",fullName:"Shailendra K. Saxena",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRET3QAO/Profile_Picture_2022-05-10T10:10:26.jpeg",biography:"Professor Dr. Shailendra K. Saxena is a vice dean and professor at King George's Medical University, Lucknow, India. His research interests involve understanding the molecular mechanisms of host defense during human viral infections and developing new predictive, preventive, and therapeutic strategies for them using Japanese encephalitis virus (JEV), HIV, and emerging viruses as a model via stem cell and cell culture technologies. His research work has been published in various high-impact factor journals (Science, PNAS, Nature Medicine) with a high number of citations. He has received many awards and honors in India and abroad including various Young Scientist Awards, BBSRC India Partnering Award, and Dr. JC Bose National Award of Department of Biotechnology, Min. of Science and Technology, Govt. of India. Dr. Saxena is a fellow of various international societies/academies including the Royal College of Pathologists, United Kingdom; Royal Society of Medicine, London; Royal Society of Biology, United Kingdom; Royal Society of Chemistry, London; and Academy of Translational Medicine Professionals, Austria. He was named a Global Leader in Science by The Scientist. He is also an international opinion leader/expert in vaccination for Japanese encephalitis by IPIC (UK).",institutionString:"King George's Medical University",institution:{name:"King George's Medical University",institutionURL:null,country:{name:"India"}}}]},{type:"book",id:"7064",title:"Current Perspectives in Human Papillomavirus",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7064.jpg",slug:"current-perspectives-in-human-papillomavirus",publishedDate:"May 2nd 2019",editedByType:"Edited by",bookSignature:"Shailendra K. Saxena",hash:"d92a4085627bab25ddc7942fbf44cf05",volumeInSeries:2,fullTitle:"Current Perspectives in Human Papillomavirus",editors:[{id:"158026",title:"Prof.",name:"Shailendra K.",middleName:null,surname:"Saxena",slug:"shailendra-k.-saxena",fullName:"Shailendra K. Saxena",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRET3QAO/Profile_Picture_2022-05-10T10:10:26.jpeg",biography:"Professor Dr. Shailendra K. Saxena is a vice dean and professor at King George's Medical University, Lucknow, India. His research interests involve understanding the molecular mechanisms of host defense during human viral infections and developing new predictive, preventive, and therapeutic strategies for them using Japanese encephalitis virus (JEV), HIV, and emerging viruses as a model via stem cell and cell culture technologies. His research work has been published in various high-impact factor journals (Science, PNAS, Nature Medicine) with a high number of citations. He has received many awards and honors in India and abroad including various Young Scientist Awards, BBSRC India Partnering Award, and Dr. JC Bose National Award of Department of Biotechnology, Min. of Science and Technology, Govt. of India. Dr. Saxena is a fellow of various international societies/academies including the Royal College of Pathologists, United Kingdom; Royal Society of Medicine, London; Royal Society of Biology, United Kingdom; Royal Society of Chemistry, London; and Academy of Translational Medicine Professionals, Austria. He was named a Global Leader in Science by The Scientist. He is also an international opinion leader/expert in vaccination for Japanese encephalitis by IPIC (UK).",institutionString:"King George's Medical University",institution:{name:"King George's Medical University",institutionURL:null,country:{name:"India"}}}]},{type:"book",id:"7123",title:"Current Topics in Neglected Tropical Diseases",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7123.jpg",slug:"current-topics-in-neglected-tropical-diseases",publishedDate:"December 4th 2019",editedByType:"Edited by",bookSignature:"Alfonso J. Rodriguez-Morales",hash:"61c627da05b2ace83056d11357bdf361",volumeInSeries:3,fullTitle:"Current Topics in Neglected Tropical Diseases",editors:[{id:"131400",title:"Prof.",name:"Alfonso J.",middleName:null,surname:"Rodriguez-Morales",slug:"alfonso-j.-rodriguez-morales",fullName:"Alfonso J. Rodriguez-Morales",profilePictureURL:"https://mts.intechopen.com/storage/users/131400/images/system/131400.png",biography:"Dr. Rodriguez-Morales is an expert in tropical and emerging diseases, particularly zoonotic and vector-borne diseases (especially arboviral diseases). He is the president of the Travel Medicine Committee of the Pan-American Infectious Diseases Association (API), as well as the president of the Colombian Association of Infectious Diseases (ACIN). He is a member of the Committee on Tropical Medicine, Zoonoses, and Travel Medicine of ACIN. He is a vice-president of the Latin American Society for Travel Medicine (SLAMVI) and a Member of the Council of the International Society for Infectious Diseases (ISID). Since 2014, he has been recognized as a Senior Researcher, at the Ministry of Science of Colombia. He is a professor at the Faculty of Medicine of the Fundacion Universitaria Autonoma de las Americas, in Pereira, Risaralda, Colombia. He is an External Professor, Master in Research on Tropical Medicine and International Health, Universitat de Barcelona, Spain. He is also a professor at the Master in Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru. In 2021 he has been awarded the “Raul Isturiz Award” Medal of the API. Also, in 2021, he was awarded with the “Jose Felix Patiño” Asclepius Staff Medal of the Colombian Medical College, due to his scientific contributions to COVID-19 during the pandemic. He is currently the Editor in Chief of the journal Travel Medicine and Infectious Diseases. His Scopus H index is 47 (Google Scholar H index, 68).",institutionString:"Institución Universitaria Visión de las Américas, Colombia",institution:null}]},{type:"book",id:"7839",title:"Malaria",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7839.jpg",slug:"malaria",publishedDate:"December 11th 2019",editedByType:"Edited by",bookSignature:"Fyson H. Kasenga",hash:"91cde4582ead884cb0f355a19b67cd56",volumeInSeries:4,fullTitle:"Malaria",editors:[{id:"86725",title:"Dr.",name:"Fyson",middleName:"Hanania",surname:"Kasenga",slug:"fyson-kasenga",fullName:"Fyson Kasenga",profilePictureURL:"https://mts.intechopen.com/storage/users/86725/images/system/86725.jpg",biography:"Dr. Kasenga is a graduate of Tumaini University, Kilimanjaro Christian Medical College, Moshi, Tanzania and Umeå University, Sweden. He obtained a Master’s degree in Public Health and PhD in Public Health and Epidemiology. He has a background in Clinical Medicine and has taken courses at higher diploma levels in public health from University of Transkei, Republic of South Africa, and African Medical and Research Foundation (AMREF) in Nairobi, Kenya. Dr. Kasenga worked in different places in and outside Malawi, and has held various positions, such as Licensed Medical Officer, HIV/AIDS Programme Officer, HIV/AIDS resource person in the International Department of Diakonhjemet College, Oslo, Norway. He also managed an Integrated HIV/AIDS Prevention programme for over 5 years. He is currently working as a Director for the Health Ministries Department of Malawi Union of the Seventh Day Adventist Church. Dr. Kasenga has published over 5 articles on HIV/AIDS issues focusing on Prevention of Mother to Child Transmission of HIV (PMTCT), including a book chapter on HIV testing counseling (currently in press). Dr. Kasenga is married to Grace and blessed with three children, a son and two daughters: Happy, Lettice and Sungani.",institutionString:"Malawi Adventist University",institution:{name:"Malawi Adventist University",institutionURL:null,country:{name:"Malawi"}}}]}]},openForSubmissionBooks:{paginationCount:1,paginationItems:[{id:"11478",title:"Recent Advances in the Study of Dyslexia",coverURL:"https://cdn.intechopen.com/books/images_new/11478.jpg",hash:"26764a18c6b776698823e0e1c3022d2f",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"June 30th 2022",isOpenForSubmission:!0,editors:[{id:"294281",title:"Prof.",name:"Jonathan",surname:"Glazzard",slug:"jonathan-glazzard",fullName:"Jonathan Glazzard"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},onlineFirstChapters:{paginationCount:10,paginationItems:[{id:"82903",title:"Walking Accessibility to Primary Healthcare Services: An Inequity Factor for Olders in the Lisbon Metropolitan Area (Portugal)",doi:"10.5772/intechopen.106265",signatures:"Eduarda Marques da Costa, Ana Louro, Nuno Marques da Costa, Mariana Dias and Marcela Barata",slug:"walking-accessibility-to-primary-healthcare-services-an-inequity-factor-for-olders-in-the-lisbon-met",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Social Aspects of Ageing - Selected Challenges, Analyses, and Solutions",coverURL:"https://cdn.intechopen.com/books/images_new/11479.jpg",subseries:{id:"90",title:"Human Development"}}},{id:"82622",title:"Contemporary Geographical Gerontology: Reconciling Space and Place in Population Ageing",doi:"10.5772/intechopen.105863",signatures:"Hamish Robertson",slug:"contemporary-geographical-gerontology-reconciling-space-and-place-in-population-ageing",totalDownloads:13,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Hamish",surname:"Robertson"}],book:{title:"Social Aspects of Ageing - Selected Challenges, Analyses, and Solutions",coverURL:"https://cdn.intechopen.com/books/images_new/11479.jpg",subseries:{id:"90",title:"Human Development"}}},{id:"82610",title:"Perspective Chapter: The Role of Learning Styles in Active Learning",doi:"10.5772/intechopen.105964",signatures:"Armando Lozano-Rodríguez, Fernanda Inez García-Vázquez and José Luis García-Cué",slug:"perspective-chapter-the-role-of-learning-styles-in-active-learning",totalDownloads:11,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Active Learning - Research and Practice",coverURL:"https://cdn.intechopen.com/books/images_new/11481.jpg",subseries:{id:"89",title:"Education"}}},{id:"81909",title:"Educational Paradigm with Ubuntu Mindset: Implications for Sustainable Development Goals in Education",doi:"10.5772/intechopen.104929",signatures:"George Frempong and Raavee Kadam",slug:"educational-paradigm-with-ubuntu-mindset-implications-for-sustainable-development-goals-in-education",totalDownloads:7,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Active Learning - Research and Practice",coverURL:"https://cdn.intechopen.com/books/images_new/11481.jpg",subseries:{id:"89",title:"Education"}}},{id:"82243",title:"The Language that Grade R Students Use to Achieve the Envisaged Mathematics Outcomes, a South African Perspective",doi:"10.5772/intechopen.105446",signatures:"Shakespear M. Chiphambo and Nosisi N. Feza",slug:"the-language-that-grade-r-students-use-to-achieve-the-envisaged-mathematics-outcomes-a-south-african",totalDownloads:3,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Active Learning - Research and Practice",coverURL:"https://cdn.intechopen.com/books/images_new/11481.jpg",subseries:{id:"89",title:"Education"}}},{id:"82394",title:"Learning by Doing Active Social Learning",doi:"10.5772/intechopen.105523",signatures:"Anat Raviv",slug:"learning-by-doing-active-social-learning",totalDownloads:11,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Active Learning - Research and Practice",coverURL:"https://cdn.intechopen.com/books/images_new/11481.jpg",subseries:{id:"89",title:"Education"}}},{id:"82310",title:"Knowledge of Intergenerational Contact to Combat Ageism towards Older People",doi:"10.5772/intechopen.105592",signatures:"Alice Nga Lai Kwong",slug:"knowledge-of-intergenerational-contact-to-combat-ageism-towards-older-people",totalDownloads:15,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Social Aspects of Ageing - Selected Challenges, Analyses, and Solutions",coverURL:"https://cdn.intechopen.com/books/images_new/11479.jpg",subseries:{id:"90",title:"Human Development"}}},{id:"81993",title:"Emergent Chemistry: Using Visualizations to Develop Abstract Thinking and a Sense of Scale Within the Preschool Setting",doi:"10.5772/intechopen.105216",signatures:"Karina Adbo",slug:"emergent-chemistry-using-visualizations-to-develop-abstract-thinking-and-a-sense-of-scale-within-the",totalDownloads:7,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Active Learning - Research and Practice",coverURL:"https://cdn.intechopen.com/books/images_new/11481.jpg",subseries:{id:"89",title:"Education"}}},{id:"82252",title:"Early Childhood: Enriched Environments and Roles of Caring Adults",doi:"10.5772/intechopen.105157",signatures:"Analía Mignaton",slug:"early-childhood-enriched-environments-and-roles-of-caring-adults",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Active Learning - Research and Practice",coverURL:"https://cdn.intechopen.com/books/images_new/11481.jpg",subseries:{id:"89",title:"Education"}}},{id:"81996",title:"Perspective Chapter: New Active Learning Models in Africa",doi:"10.5772/intechopen.105217",signatures:"Fred Awaah, Cosmas Lambini Kombat and Emmanuel Okyere Ekwam",slug:"perspective-chapter-new-active-learning-models-in-africa",totalDownloads:9,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Active Learning - Research and Practice",coverURL:"https://cdn.intechopen.com/books/images_new/11481.jpg",subseries:{id:"89",title:"Education"}}}]},subseriesFiltersForOFChapters:[{caption:"Human Development",value:90,count:3,group:"subseries"},{caption:"Education",value:89,count:7,group:"subseries"}],publishedBooks:{paginationCount:13,paginationItems:[{type:"book",id:"7102",title:"Pneumonia",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7102.jpg",slug:"pneumonia",publishedDate:"May 11th 2022",editedByType:"Edited by",bookSignature:"Nima Rezaei",hash:"9fd70142814192dcec58a176749f1b60",volumeInSeries:13,fullTitle:"Pneumonia",editors:[{id:"116250",title:"Dr.",name:"Nima",middleName:null,surname:"Rezaei",slug:"nima-rezaei",fullName:"Nima Rezaei",profilePictureURL:"https://mts.intechopen.com/storage/users/116250/images/system/116250.jpg",institutionString:"Tehran University of Medical Sciences",institution:{name:"Tehran University of Medical Sciences",institutionURL:null,country:{name:"Iran"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9615",title:"Chikungunya Virus",subtitle:"A Growing Global Public Health Threat",coverURL:"https://cdn.intechopen.com/books/images_new/9615.jpg",slug:"chikungunya-virus-a-growing-global-public-health-threat",publishedDate:"February 9th 2022",editedByType:"Edited by",bookSignature:"Jean Engohang-Ndong",hash:"c960d94a63867dd12a8ab15176a3ff06",volumeInSeries:12,fullTitle:"Chikungunya Virus - A Growing Global Public Health Threat",editors:[{id:"180733",title:"Dr.",name:"Jean",middleName:null,surname:"Engohang-Ndong",slug:"jean-engohang-ndong",fullName:"Jean Engohang-Ndong",profilePictureURL:"https://mts.intechopen.com/storage/users/180733/images/system/180733.png",institutionString:"Kent State University",institution:{name:"Kent State University",institutionURL:null,country:{name:"United States of America"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9619",title:"Epstein-Barr Virus",subtitle:"New Trends",coverURL:"https://cdn.intechopen.com/books/images_new/9619.jpg",slug:"epstein-barr-virus-new-trends",publishedDate:"December 22nd 2021",editedByType:"Edited by",bookSignature:"Emmanuel Drouet",hash:"a2128c53becb6064589570cbe8d976f8",volumeInSeries:11,fullTitle:"Epstein-Barr Virus - New Trends",editors:[{id:"188773",title:"Prof.",name:"Emmanuel",middleName:null,surname:"Drouet",slug:"emmanuel-drouet",fullName:"Emmanuel Drouet",profilePictureURL:"https://mts.intechopen.com/storage/users/188773/images/system/188773.png",institutionString:null,institution:{name:"Grenoble Alpes University",institutionURL:null,country:{name:"France"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9525",title:"Insights Into Drug Resistance in Staphylococcus aureus",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9525.jpg",slug:"insights-into-drug-resistance-in-staphylococcus-aureus",publishedDate:"December 8th 2021",editedByType:"Edited by",bookSignature:"Amjad Aqib",hash:"98bb6c1ddb067da67185c272f81c0a27",volumeInSeries:10,fullTitle:"Insights Into Drug Resistance in Staphylococcus aureus",editors:[{id:"229220",title:"Dr.",name:"Amjad",middleName:"Islam",surname:"Aqib",slug:"amjad-aqib",fullName:"Amjad Aqib",profilePictureURL:"https://mts.intechopen.com/storage/users/229220/images/system/229220.png",institutionString:"Cholistan University of Veterinary and Animal Sciences",institution:{name:"University of Agriculture Faisalabad",institutionURL:null,country:{name:"Pakistan"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9614",title:"Advances in Candida albicans",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9614.jpg",slug:"advances-in-candida-albicans",publishedDate:"November 17th 2021",editedByType:"Edited by",bookSignature:"Xinhui Wang",hash:"31d6882518ca749b12715266eed0a018",volumeInSeries:9,fullTitle:"Advances in Candida albicans",editors:[{id:"296531",title:"Dr.",name:"Xinhui",middleName:null,surname:"Wang",slug:"xinhui-wang",fullName:"Xinhui Wang",profilePictureURL:"https://mts.intechopen.com/storage/users/296531/images/system/296531.jpg",institutionString:"Qinghai Normal University",institution:{name:"University of Luxembourg",institutionURL:null,country:{name:"Luxembourg"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9528",title:"Current Topics and Emerging Issues in Malaria Elimination",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9528.jpg",slug:"current-topics-and-emerging-issues-in-malaria-elimination",publishedDate:"July 21st 2021",editedByType:"Edited by",bookSignature:"Alfonso J. Rodriguez-Morales",hash:"7f178329cc42e691efe226b32f14e2ea",volumeInSeries:8,fullTitle:"Current Topics and Emerging Issues in Malaria Elimination",editors:[{id:"131400",title:"Prof.",name:"Alfonso J.",middleName:null,surname:"Rodriguez-Morales",slug:"alfonso-j.-rodriguez-morales",fullName:"Alfonso J. Rodriguez-Morales",profilePictureURL:"https://mts.intechopen.com/storage/users/131400/images/system/131400.png",institutionString:"Institución Universitaria Visión de las Américas, Colombia",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9613",title:"Dengue Fever in a One Health Perspective",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9613.jpg",slug:"dengue-fever-in-a-one-health-perspective",publishedDate:"October 28th 2020",editedByType:"Edited by",bookSignature:"Márcia Aparecida Sperança",hash:"77ecce8195c11092230b4156df6d83ff",volumeInSeries:7,fullTitle:"Dengue Fever in a One Health Perspective",editors:[{id:"176579",title:"Dr.",name:"Márcia Aparecida",middleName:null,surname:"Sperança",slug:"marcia-aparecida-speranca",fullName:"Márcia Aparecida Sperança",profilePictureURL:"https://mts.intechopen.com/storage/users/176579/images/system/176579.jpg",institutionString:null,institution:{name:"Universidade Federal do ABC",institutionURL:null,country:{name:"Brazil"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7981",title:"Overview on Echinococcosis",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7981.jpg",slug:"overview-on-echinococcosis",publishedDate:"April 22nd 2020",editedByType:"Edited by",bookSignature:"Fethi Derbel and Meriem Braiki",hash:"24dee9209f3fd6b7cd28f042da0076f0",volumeInSeries:6,fullTitle:"Overview on Echinococcosis",editors:[{id:"62900",title:"Prof.",name:"Fethi",middleName:null,surname:"Derbel",slug:"fethi-derbel",fullName:"Fethi Derbel",profilePictureURL:"https://mts.intechopen.com/storage/users/62900/images/system/62900.jpeg",institutionString:"Clinique les Oliviers",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7887",title:"Hepatitis B and C",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7887.jpg",slug:"hepatitis-b-and-c",publishedDate:"April 8th 2020",editedByType:"Edited by",bookSignature:"Luis Rodrigo",hash:"8dd6dab483cf505d83caddaeaf497f2c",volumeInSeries:5,fullTitle:"Hepatitis B and C",editors:[{id:"73208",title:"Prof.",name:"Luis",middleName:null,surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo",profilePictureURL:"https://mts.intechopen.com/storage/users/73208/images/system/73208.jpg",institutionString:"University of Oviedo",institution:{name:"University of Oviedo",institutionURL:null,country:{name:"Spain"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7839",title:"Malaria",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7839.jpg",slug:"malaria",publishedDate:"December 11th 2019",editedByType:"Edited by",bookSignature:"Fyson H. Kasenga",hash:"91cde4582ead884cb0f355a19b67cd56",volumeInSeries:4,fullTitle:"Malaria",editors:[{id:"86725",title:"Dr.",name:"Fyson",middleName:"Hanania",surname:"Kasenga",slug:"fyson-kasenga",fullName:"Fyson Kasenga",profilePictureURL:"https://mts.intechopen.com/storage/users/86725/images/system/86725.jpg",institutionString:"Malawi Adventist University",institution:{name:"Malawi Adventist University",institutionURL:null,country:{name:"Malawi"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7123",title:"Current Topics in Neglected Tropical Diseases",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7123.jpg",slug:"current-topics-in-neglected-tropical-diseases",publishedDate:"December 4th 2019",editedByType:"Edited by",bookSignature:"Alfonso J. Rodriguez-Morales",hash:"61c627da05b2ace83056d11357bdf361",volumeInSeries:3,fullTitle:"Current Topics in Neglected Tropical Diseases",editors:[{id:"131400",title:"Prof.",name:"Alfonso J.",middleName:null,surname:"Rodriguez-Morales",slug:"alfonso-j.-rodriguez-morales",fullName:"Alfonso J. Rodriguez-Morales",profilePictureURL:"https://mts.intechopen.com/storage/users/131400/images/system/131400.png",institutionString:"Institución Universitaria Visión de las Américas, Colombia",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7064",title:"Current Perspectives in Human Papillomavirus",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7064.jpg",slug:"current-perspectives-in-human-papillomavirus",publishedDate:"May 2nd 2019",editedByType:"Edited by",bookSignature:"Shailendra K. Saxena",hash:"d92a4085627bab25ddc7942fbf44cf05",volumeInSeries:2,fullTitle:"Current Perspectives in Human Papillomavirus",editors:[{id:"158026",title:"Prof.",name:"Shailendra K.",middleName:null,surname:"Saxena",slug:"shailendra-k.-saxena",fullName:"Shailendra K. Saxena",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRET3QAO/Profile_Picture_2022-05-10T10:10:26.jpeg",institutionString:"King George's Medical University",institution:{name:"King George's Medical University",institutionURL:null,country:{name:"India"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},subseriesFiltersForPublishedBooks:[{group:"subseries",caption:"Bacterial Infectious Diseases",value:3,count:2},{group:"subseries",caption:"Parasitic Infectious Diseases",value:5,count:4},{group:"subseries",caption:"Viral Infectious Diseases",value:6,count:7}],publicationYearFilters:[{group:"publicationYear",caption:"2022",value:2022,count:2},{group:"publicationYear",caption:"2021",value:2021,count:4},{group:"publicationYear",caption:"2020",value:2020,count:3},{group:"publicationYear",caption:"2019",value:2019,count:3},{group:"publicationYear",caption:"2018",value:2018,count:1}],authors:{paginationCount:30,paginationItems:[{id:"425474",title:"Mr.",name:"Jasper",middleName:"Okoro Godwin",surname:"Okoro Godwin Elechi",slug:"jasper-okoro-godwin-elechi",fullName:"Jasper Okoro Godwin Elechi",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/425474/images/19990_n.jpg",biography:"Mr. Elechi is an innovative and passionate food professional and educator who can collaborate across boundaries with an integrated aspiration of innovation to provide good, sustainable, and healthy food solutions that promote human health and conserve planetary health. He has a special interest in innovative food product development, nutrition, indigenous food products, biotechnology, bioeconmy, sustainable global food systems transformation, food safety Nanotechnology, and Nanomaterials. He has carried out independent research and publications in these areas. He possesses comprehensive knowledge and technical know-how on nutritional formulation and production of healthy and sustainable foods from locally available underutilized Cereal-Legume crops for combating food security and malnutrition in developing communities.",institutionString:null,institution:null},{id:"307387",title:"Dr.",name:"Cecilia",middleName:null,surname:"Camporeale",slug:"cecilia-camporeale",fullName:"Cecilia Camporeale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"National Agency For New Technologies, Energy and Sustainable Economic Development",country:{name:"Italy"}}},{id:"296882",title:"Dr.",name:"Mario",middleName:null,surname:"Jorizzo",slug:"mario-jorizzo",fullName:"Mario Jorizzo",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"National Agency For New Technologies, Energy and Sustainable Economic Development",country:{name:"Italy"}}},{id:"307388",title:"Dr.",name:"ROBERTO",middleName:null,surname:"DEL CIELLO",slug:"roberto-del-ciello",fullName:"ROBERTO DEL CIELLO",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"National Agency For New Technologies, Energy and Sustainable Economic Development",country:{name:"Italy"}}},{id:"437647",title:"M.Sc.",name:"Fernando",middleName:null,surname:"Teixeira",slug:"fernando-teixeira",fullName:"Fernando Teixeira",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Évora",country:{name:"Portugal"}}},{id:"423338",title:"Dr.",name:"Harjeet",middleName:null,surname:"Singh",slug:"harjeet-singh",fullName:"Harjeet Singh",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Chitkara University",country:{name:"India"}}},{id:"443635",title:"Dr.",name:"Suruchi",middleName:null,surname:"Jindal",slug:"suruchi-jindal",fullName:"Suruchi Jindal",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Punjab Agricultural University",country:{name:"India"}}},{id:"426265",title:"Mrs.",name:"Inonge",middleName:null,surname:"Chibua",slug:"inonge-chibua",fullName:"Inonge Chibua",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Botswana",country:{name:"Botswana"}}},{id:"426266",title:"Ms.",name:"Mesha",middleName:null,surname:"Mbisana",slug:"mesha-mbisana",fullName:"Mesha Mbisana",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Botswana",country:{name:"Botswana"}}},{id:"426264",title:"Mr.",name:"Samuel",middleName:null,surname:"Raditloko",slug:"samuel-raditloko",fullName:"Samuel Raditloko",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Botswana",country:{name:"Botswana"}}},{id:"426394",title:"Dr.",name:"Mags",middleName:null,surname:"Adams",slug:"mags-adams",fullName:"Mags Adams",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Central Lancashire",country:{name:"United Kingdom"}}},{id:"441182",title:"Dr.",name:"Neil",middleName:null,surname:"Wilson",slug:"neil-wilson",fullName:"Neil Wilson",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Central Lancashire",country:{name:"United Kingdom"}}},{id:"425171",title:"Ph.D. Student",name:"Tanya",middleName:null,surname:"Zerbian",slug:"tanya-zerbian",fullName:"Tanya Zerbian",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Central Lancashire",country:{name:"Cyprus"}}},{id:"424714",title:"Prof.",name:"Elke",middleName:null,surname:"Stedefeldt",slug:"elke-stedefeldt",fullName:"Elke Stedefeldt",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Federal University of Sao Paulo",country:{name:"Brazil"}}},{id:"425244",title:"Dr.",name:"Rayane",middleName:"Stephanie Gomes",surname:"Stephanie Gomes De Freitas",slug:"rayane-stephanie-gomes-de-freitas",fullName:"Rayane Stephanie Gomes De Freitas",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Federal University of Sao Paulo",country:{name:"Brazil"}}},{id:"424688",title:"Dr.",name:"Bart",middleName:null,surname:"de Steenhuijsen Piters",slug:"bart-de-steenhuijsen-piters",fullName:"Bart de Steenhuijsen Piters",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Wageningen University & Research",country:{name:"Netherlands"}}},{id:"429404",title:"Dr.",name:"Emma",middleName:null,surname:"Termeer",slug:"emma-termeer",fullName:"Emma Termeer",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Wageningen University & Research",country:{name:"Netherlands"}}},{id:"429407",title:"Dr.",name:"Herman",middleName:null,surname:"Brouwer",slug:"herman-brouwer",fullName:"Herman Brouwer",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Wageningen University & Research",country:{name:"Netherlands"}}},{id:"429406",title:"Dr.",name:"Hubert",middleName:null,surname:"Fonteijn",slug:"hubert-fonteijn",fullName:"Hubert Fonteijn",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Wageningen University & Research",country:{name:"Netherlands"}}},{id:"427504",title:"Dr.",name:"Kriengsak",middleName:null,surname:"Chareonwongsak",slug:"kriengsak-chareonwongsak",fullName:"Kriengsak Chareonwongsak",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"423333",title:"Ph.D. Student",name:"Shivani",middleName:null,surname:"Sood",slug:"shivani-sood",fullName:"Shivani Sood",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"452297",title:"Mr.",name:"Cornelius",middleName:null,surname:"Smah Adamu",slug:"cornelius-smah-adamu",fullName:"Cornelius Smah Adamu",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"452296",title:"Mr.",name:"Ikechukwu",middleName:null,surname:"U. Nwiyi",slug:"ikechukwu-u.-nwiyi",fullName:"Ikechukwu U. Nwiyi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"423395",title:"Assistant Prof.",name:"Adane",middleName:null,surname:"Atara Debessa",slug:"adane-atara-debessa",fullName:"Adane Atara Debessa",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"426267",title:"Mr.",name:"Banyaladzi",middleName:null,surname:"Paphane",slug:"banyaladzi-paphane",fullName:"Banyaladzi Paphane",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"483388",title:"Dr.",name:"Berhanu",middleName:null,surname:"Denu",slug:"berhanu-denu",fullName:"Berhanu Denu",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"483387",title:"Dr.",name:"Degefa",middleName:null,surname:"Tolossa",slug:"degefa-tolossa",fullName:"Degefa Tolossa",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"426059",title:"Dr.",name:"Dikabo",middleName:null,surname:"Mogopodi",slug:"dikabo-mogopodi",fullName:"Dikabo Mogopodi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"422909",title:"Dr.",name:"Dorcas Stella",middleName:null,surname:"Shumba",slug:"dorcas-stella-shumba",fullName:"Dorcas Stella Shumba",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"429405",title:"Dr.",name:"Deborah",middleName:null,surname:"Bakker",slug:"deborah-bakker",fullName:"Deborah Bakker",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]}},subseries:{item:{id:"14",type:"subseries",title:"Cell and Molecular Biology",keywords:"Omics (Transcriptomics; Proteomics; Metabolomics), Molecular Biology, Cell Biology, Signal Transduction and Regulation, Cell Growth and Differentiation, Apoptosis, Necroptosis, Ferroptosis, Autophagy, Cell Cycle, Macromolecules and Complexes, Gene Expression",scope:"The Cell and Molecular Biology topic within the IntechOpen Biochemistry Series aims to rapidly publish contributions on all aspects of cell and molecular biology, including aspects related to biochemical and genetic research (not only in humans but all living beings). We encourage the submission of manuscripts that provide novel and mechanistic insights that report significant advances in the fields. Topics include, but are not limited to: Advanced techniques of cellular and molecular biology (Molecular methodologies, imaging techniques, and bioinformatics); Biological activities at the molecular level; Biological processes of cell functions, cell division, senescence, maintenance, and cell death; Biomolecules interactions; Cancer; Cell biology; Chemical biology; Computational biology; Cytochemistry; Developmental biology; Disease mechanisms and therapeutics; DNA, and RNA metabolism; Gene functions, genetics, and genomics; Genetics; Immunology; Medical microbiology; Molecular biology; Molecular genetics; Molecular processes of cell and organelle dynamics; Neuroscience; Protein biosynthesis, degradation, and functions; Regulation of molecular interactions in a cell; Signalling networks and system biology; Structural biology; Virology and microbiology.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/14.jpg",hasOnlineFirst:!0,hasPublishedBooks:!0,annualVolume:11410,editor:{id:"165627",title:"Dr.",name:"Rosa María",middleName:null,surname:"Martínez-Espinosa",slug:"rosa-maria-martinez-espinosa",fullName:"Rosa María Martínez-Espinosa",profilePictureURL:"https://mts.intechopen.com/storage/users/165627/images/system/165627.jpeg",biography:"Dr. Rosa María Martínez-Espinosa has been a Spanish Full Professor since 2020 (Biochemistry and Molecular Biology) and is currently Vice-President of International Relations and Cooperation development and leader of the research group 'Applied Biochemistry” (University of Alicante, Spain). Other positions she has held at the university include Vice-Dean of Master Programs, Vice-Dean of the Degree in Biology and Vice-Dean for Mobility and Enterprise and Engagement at the Faculty of Science (University of Alicante). She received her Bachelor in Biology in 1998 (University of Alicante) and her PhD in 2003 (Biochemistry, University of Alicante). She undertook post-doctoral research at the University of East Anglia (Norwich, U.K. 2004-2005; 2007-2008).\nHer multidisciplinary research focuses on investigating archaea and their potential applications in biotechnology. She has an H-index of 21. She has authored one patent and has published more than 70 indexed papers and around 60 book chapters.\nShe has contributed to more than 150 national and international meetings during the last 15 years. Her research interests include archaea metabolism, enzymes purification and characterization, gene regulation, carotenoids and bioplastics production, antioxidant\ncompounds, waste water treatments, and brines bioremediation.\nRosa María’s other roles include editorial board member for several journals related\nto biochemistry, reviewer for more than 60 journals (biochemistry, molecular biology, biotechnology, chemistry and microbiology) and president of several organizing committees in international meetings related to the N-cycle or respiratory processes.",institutionString:null,institution:{name:"University of Alicante",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null,series:{id:"11",title:"Biochemistry",doi:"10.5772/intechopen.72877",issn:"2632-0983"},editorialBoard:[{id:"79367",title:"Dr.",name:"Ana Isabel",middleName:null,surname:"Flores",slug:"ana-isabel-flores",fullName:"Ana Isabel Flores",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRpIOQA0/Profile_Picture_1632418099564",institutionString:null,institution:{name:"Hospital Universitario 12 De Octubre",institutionURL:null,country:{name:"Spain"}}},{id:"328234",title:"Ph.D.",name:"Christian",middleName:null,surname:"Palavecino",slug:"christian-palavecino",fullName:"Christian Palavecino",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000030DhEhQAK/Profile_Picture_1628835318625",institutionString:null,institution:{name:"Central University of Chile",institutionURL:null,country:{name:"Chile"}}},{id:"186585",title:"Dr.",name:"Francisco Javier",middleName:null,surname:"Martin-Romero",slug:"francisco-javier-martin-romero",fullName:"Francisco Javier Martin-Romero",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSB3HQAW/Profile_Picture_1631258137641",institutionString:null,institution:{name:"University of Extremadura",institutionURL:null,country:{name:"Spain"}}}]},onlineFirstChapters:{paginationCount:17,paginationItems:[{id:"82751",title:"Mitochondria-Endoplasmic Reticulum Interaction in Central Neurons",doi:"10.5772/intechopen.105738",signatures:"Liliya Kushnireva and Eduard Korkotian",slug:"mitochondria-endoplasmic-reticulum-interaction-in-central-neurons",totalDownloads:6,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Endoplasmic Reticulum",coverURL:"https://cdn.intechopen.com/books/images_new/11674.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"82716",title:"Advanced glycation end product induced endothelial dysfunction through ER stress: Unravelling the role of Paraoxonase 2",doi:"10.5772/intechopen.106018",signatures:"Ramya Ravi and Bharathidevi Subramaniam Rajesh",slug:"advanced-glycation-end-product-induced-endothelial-dysfunction-through-er-stress-unravelling-the-rol",totalDownloads:12,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Endoplasmic Reticulum",coverURL:"https://cdn.intechopen.com/books/images_new/11674.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"82195",title:"Endoplasmic Reticulum: A Hub in Lipid Homeostasis",doi:"10.5772/intechopen.105450",signatures:"Raúl Ventura and María Isabel Hernández-Alvarez",slug:"endoplasmic-reticulum-a-hub-in-lipid-homeostasis",totalDownloads:16,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Endoplasmic Reticulum",coverURL:"https://cdn.intechopen.com/books/images_new/11674.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"82103",title:"The Role of Endoplasmic Reticulum Stress and Its Regulation in the Progression of Neurological and Infectious Diseases",doi:"10.5772/intechopen.105543",signatures:"Mary Dover, Michael Kishek, Miranda Eddins, Naneeta Desar, Ketema Paul and Milan Fiala",slug:"the-role-of-endoplasmic-reticulum-stress-and-its-regulation-in-the-progression-of-neurological-and-i",totalDownloads:15,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Endoplasmic Reticulum",coverURL:"https://cdn.intechopen.com/books/images_new/11674.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"80954",title:"Ion Channels and Neurodegenerative Disease Aging Related",doi:"10.5772/intechopen.103074",signatures:"Marika Cordaro, Salvatore Cuzzocrea and Rosanna Di Paola",slug:"ion-channels-and-neurodegenerative-disease-aging-related",totalDownloads:12,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Ion Channels - From Basic Properties to Medical Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10838.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"81647",title:"Diabetes and Epigenetics",doi:"10.5772/intechopen.104653",signatures:"Rasha A. Alhazzaa, Thomas Heinbockel and Antonei B. Csoka",slug:"diabetes-and-epigenetics",totalDownloads:41,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Epigenetics to Optogenetics - A New Paradigm in the Study of Biology",coverURL:"https://cdn.intechopen.com/books/images_new/9672.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"81099",title:"SK Channels and Heart Disease",doi:"10.5772/intechopen.104115",signatures:"Katherine Zhong, Shawn Kant, Frank Sellke and Jun Feng",slug:"sk-channels-and-heart-disease",totalDownloads:26,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Ion Channels - From Basic Properties to Medical Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10838.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"80967",title:"Hot on the Trail of Skin Inflammation: Focus on TRPV1/TRPV3 Channels in Psoriasis",doi:"10.5772/intechopen.103792",signatures:"Lisa S. Martin, Emma Fraillon, Fabien P. Chevalier and Bérengère Fromy",slug:"hot-on-the-trail-of-skin-inflammation-focus-on-trpv1-trpv3-channels-in-psoriasis",totalDownloads:53,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Ion Channels - From Basic Properties to Medical Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10838.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"80952",title:"TRPV Family Ion Channels in the Mammary Epithelium: Role in Normal Tissue Homeostasis and along Breast Cancer Progression",doi:"10.5772/intechopen.103665",signatures:"Sari Susanna Tojkander",slug:"trpv-family-ion-channels-in-the-mammary-epithelium-role-in-normal-tissue-homeostasis-and-along-breas",totalDownloads:23,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Ion Channels - From Basic Properties to Medical Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10838.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"80157",title:"Structural Determinants for Ligand Accommodation in Voltage Sensors",doi:"10.5772/intechopen.102094",signatures:"Abigail García-Morales, Aylin López-Palestino and Daniel Balleza",slug:"structural-determinants-for-ligand-accommodation-in-voltage-sensors",totalDownloads:108,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Ion Channels - From Basic Properties to Medical Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10838.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"79690",title:"Mitochondrial Channels and their Role in Cardioprotection",doi:"10.5772/intechopen.101127",signatures:"Keerti Mishra and Min Luo",slug:"mitochondrial-channels-and-their-role-in-cardioprotection",totalDownloads:113,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Ion Channels - From Basic Properties to Medical Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10838.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"78415",title:"Epigenetic",doi:"10.5772/intechopen.99964",signatures:"Mehmet Ünal",slug:"epigenetic",totalDownloads:153,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Epigenetics to Optogenetics - A New Paradigm in the Study of Biology",coverURL:"https://cdn.intechopen.com/books/images_new/9672.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"77443",title:"Cyanobacterial Phytochromes in Optogenetics",doi:"10.5772/intechopen.97522",signatures:"Sivasankari Sivaprakasam, Vinoth Mani, Nagalakshmi Balasubramaniyan and David Ravindran Abraham",slug:"cyanobacterial-phytochromes-in-optogenetics",totalDownloads:209,totalCrossrefCites:0,totalDimensionsCites:1,authors:null,book:{title:"Epigenetics to Optogenetics - A New Paradigm in the Study of Biology",coverURL:"https://cdn.intechopen.com/books/images_new/9672.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"75979",title:"Spatiotemporal Regulation of Cell–Cell Adhesions",doi:"10.5772/intechopen.97009",signatures:"Brent M. Bijonowski",slug:"spatiotemporal-regulation-of-cell-cell-adhesions",totalDownloads:184,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Epigenetics to Optogenetics - A New Paradigm in the Study of Biology",coverURL:"https://cdn.intechopen.com/books/images_new/9672.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"76646",title:"Functional Mechanism of Proton Pump-Type Rhodopsins Found in Various Microorganisms as a Potential Effective Tool in Optogenetics",doi:"10.5772/intechopen.97589",signatures:"Jun Tamogami and Takashi Kikukawa",slug:"functional-mechanism-of-proton-pump-type-rhodopsins-found-in-various-microorganisms-as-a-potential-e",totalDownloads:239,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Epigenetics to Optogenetics - A New Paradigm in the Study of Biology",coverURL:"https://cdn.intechopen.com/books/images_new/9672.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"76510",title:"Evolution of Epigenome as the Blueprint for Carcinogenesis",doi:"10.5772/intechopen.97379",signatures:"Zeenat Farooq, Ambreen Shah, Mohammad Tauseef, Riyaz Ahmad Rather and Mumtaz Anwar",slug:"evolution-of-epigenome-as-the-blueprint-for-carcinogenesis",totalDownloads:205,totalCrossrefCites:1,totalDimensionsCites:1,authors:null,book:{title:"Epigenetics to Optogenetics - A New Paradigm in the Study of Biology",coverURL:"https://cdn.intechopen.com/books/images_new/9672.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}}]},publishedBooks:{paginationCount:2,paginationItems:[{type:"book",id:"9525",title:"Insights Into Drug Resistance in Staphylococcus aureus",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9525.jpg",slug:"insights-into-drug-resistance-in-staphylococcus-aureus",publishedDate:"December 8th 2021",editedByType:"Edited by",bookSignature:"Amjad Aqib",hash:"98bb6c1ddb067da67185c272f81c0a27",volumeInSeries:10,fullTitle:"Insights Into Drug Resistance in Staphylococcus aureus",editors:[{id:"229220",title:"Dr.",name:"Amjad",middleName:"Islam",surname:"Aqib",slug:"amjad-aqib",fullName:"Amjad Aqib",profilePictureURL:"https://mts.intechopen.com/storage/users/229220/images/system/229220.png",institutionString:"Cholistan University of Veterinary and Animal Sciences",institution:{name:"University of Agriculture Faisalabad",institutionURL:null,country:{name:"Pakistan"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9614",title:"Advances in Candida albicans",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9614.jpg",slug:"advances-in-candida-albicans",publishedDate:"November 17th 2021",editedByType:"Edited by",bookSignature:"Xinhui Wang",hash:"31d6882518ca749b12715266eed0a018",volumeInSeries:9,fullTitle:"Advances in Candida albicans",editors:[{id:"296531",title:"Dr.",name:"Xinhui",middleName:null,surname:"Wang",slug:"xinhui-wang",fullName:"Xinhui Wang",profilePictureURL:"https://mts.intechopen.com/storage/users/296531/images/system/296531.jpg",institutionString:"Qinghai Normal University",institution:{name:"University of Luxembourg",institutionURL:null,country:{name:"Luxembourg"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},testimonialsList:[{id:"27",text:"The opportunity to work with a prestigious publisher allows for the possibility to collaborate with more research groups interested in animal nutrition, leading to the development of new feeding strategies and food valuation while being more sustainable with the environment, allowing more readers to learn about the subject.",author:{id:"175967",name:"Manuel",surname:"Gonzalez Ronquillo",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/175967/images/system/175967.png",slug:"manuel-gonzalez-ronquillo",institution:{id:"6221",name:"Universidad Autónoma del Estado de México",country:{id:null,name:"Mexico"}}}},{id:"18",text:"It was great publishing with IntechOpen, the process was straightforward and I had support all along.",author:{id:"71579",name:"Berend",surname:"Olivier",institutionString:"Utrecht University",profilePictureURL:"https://mts.intechopen.com/storage/users/71579/images/system/71579.png",slug:"berend-olivier",institution:{id:"253",name:"Utrecht University",country:{id:null,name:"Netherlands"}}}},{id:"8",text:"I work with IntechOpen for a number of reasons: their professionalism, their mission in support of Open Access publishing, and the quality of their peer-reviewed publications, but also because they believe in equality.",author:{id:"202192",name:"Catrin",surname:"Rutland",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",slug:"catrin-rutland",institution:{id:"134",name:"University of Nottingham",country:{id:null,name:"United Kingdom"}}}}]},submityourwork:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:9,numberOfPublishedChapters:90,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:107,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:33,numberOfPublishedChapters:330,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:14,numberOfPublishedChapters:145,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:9,numberOfPublishedChapters:139,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:122,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:112,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:21,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:10,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:"2753-6580",doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],subseriesList:[{id:"7",title:"Bioinformatics and Medical Informatics",scope:"Bioinformatics aims to help understand the functioning of the mechanisms of living organisms through the construction and use of quantitative tools. The applications of this research cover many related fields, such as biotechnology and medicine, where, for example, Bioinformatics contributes to faster drug design, DNA analysis in forensics, and DNA sequence analysis in the field of personalized medicine. Personalized medicine is a type of medical care in which treatment is customized individually for each patient. Personalized medicine enables more effective therapy, reduces the costs of therapy and clinical trials, and also minimizes the risk of side effects. Nevertheless, advances in personalized medicine would not have been possible without bioinformatics, which can analyze the human genome and other vast amounts of biomedical data, especially in genetics. The rapid growth of information technology enabled the development of new tools to decode human genomes, large-scale studies of genetic variations and medical informatics. The considerable development of technology, including the computing power of computers, is also conducive to the development of bioinformatics, including personalized medicine. In an era of rapidly growing data volumes and ever lower costs of generating, storing and computing data, personalized medicine holds great promises. Modern computational methods used as bioinformatics tools can integrate multi-scale, multi-modal and longitudinal patient data to create even more effective and safer therapy and disease prevention methods. Main aspects of the topic are: Applying bioinformatics in drug discovery and development; Bioinformatics in clinical diagnostics (genetic variants that act as markers for a condition or a disease); Blockchain and Artificial Intelligence/Machine Learning in personalized medicine; Customize disease-prevention strategies in personalized medicine; Big data analysis in personalized medicine; Translating stratification algorithms into clinical practice of personalized medicine.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/7.jpg",keywords:"Biomedical Data, Drug Discovery, Clinical Diagnostics, Decoding Human Genome, AI in Personalized Medicine, Disease-prevention Strategies, Big Data Analysis in Medicine"},{id:"8",title:"Bioinspired Technology and Biomechanics",scope:'Bioinspired technologies take advantage of understanding the actual biological system to provide solutions to problems in several areas. Recently, bioinspired systems have been successfully employing biomechanics to develop and improve assistive technology and rehabilitation devices. The research topic "Bioinspired Technology and Biomechanics" welcomes studies reporting recent advances in bioinspired technologies that contribute to individuals\' health, inclusion, and rehabilitation. Possible contributions can address (but are not limited to) the following research topics: Bioinspired design and control of exoskeletons, orthoses, and prostheses; Experimental evaluation of the effect of assistive devices (e.g., influence on gait, balance, and neuromuscular system); Bioinspired technologies for rehabilitation, including clinical studies reporting evaluations; Application of neuromuscular and biomechanical models to the development of bioinspired technology.',coverUrl:"https://cdn.intechopen.com/series_topics/covers/8.jpg",keywords:"Bioinspired Systems, Biomechanics, Assistive Technology, Rehabilitation"},{id:"9",title:"Biotechnology - Biosensors, Biomaterials and Tissue Engineering",scope:"The Biotechnology - Biosensors, Biomaterials and Tissue Engineering topic within the Biomedical Engineering Series aims to rapidly publish contributions on all aspects of biotechnology, biosensors, biomaterial and tissue engineering. We encourage the submission of manuscripts that provide novel and mechanistic insights that report significant advances in the fields. Topics can include but are not limited to: Biotechnology such as biotechnological products and process engineering; Biotechnologically relevant enzymes and proteins; Bioenergy and biofuels; Applied genetics and molecular biotechnology; Genomics, transcriptomics, proteomics; Applied microbial and cell physiology; Environmental biotechnology; Methods and protocols. Moreover, topics in biosensor technology, like sensors that incorporate enzymes, antibodies, nucleic acids, whole cells, tissues and organelles, and other biological or biologically inspired components will be considered, and topics exploring transducers, including those based on electrochemical and optical piezoelectric, thermal, magnetic, and micromechanical elements. Chapters exploring biomaterial approaches such as polymer synthesis and characterization, drug and gene vector design, biocompatibility, immunology and toxicology, and self-assembly at the nanoscale, are welcome. Finally, the tissue engineering subcategory will support topics such as the fundamentals of stem cells and progenitor cells and their proliferation, differentiation, bioreactors for three-dimensional culture and studies of phenotypic changes, stem and progenitor cells, both short and long term, ex vivo and in vivo implantation both in preclinical models and also in clinical trials.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/9.jpg",keywords:"Biotechnology, Biosensors, Biomaterials, Tissue Engineering"}],annualVolumeBook:{},thematicCollection:[],selectedSeries:null,selectedSubseries:null},seriesLanding:{item:{id:"7",title:"Biomedical Engineering",doi:"10.5772/intechopen.71985",issn:"2631-5343",scope:"Biomedical Engineering is one of the fastest-growing interdisciplinary branches of science and industry. The combination of electronics and computer science with biology and medicine has improved patient diagnosis, reduced rehabilitation time, and helped to facilitate a better quality of life. Nowadays, all medical imaging devices, medical instruments, or new laboratory techniques result from the cooperation of specialists in various fields. The series of Biomedical Engineering books covers such areas of knowledge as chemistry, physics, electronics, medicine, and biology. This series is intended for doctors, engineers, and scientists involved in biomedical engineering or those wanting to start working in this field.",coverUrl:"https://cdn.intechopen.com/series/covers/7.jpg",latestPublicationDate:"August 3rd, 2022",hasOnlineFirst:!0,numberOfOpenTopics:3,numberOfPublishedChapters:107,numberOfPublishedBooks:12,editor:{id:"50150",title:"Prof.",name:"Robert",middleName:null,surname:"Koprowski",fullName:"Robert Koprowski",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYTYNQA4/Profile_Picture_1630478535317",biography:"Robert Koprowski, MD (1997), PhD (2003), Habilitation (2015), is an employee of the University of Silesia, Poland, Institute of Computer Science, Department of Biomedical Computer Systems. For 20 years, he has studied the analysis and processing of biomedical images, emphasizing the full automation of measurement for a large inter-individual variability of patients. Dr. Koprowski has authored more than a hundred research papers with dozens in impact factor (IF) journals and has authored or co-authored six books. Additionally, he is the author of several national and international patents in the field of biomedical devices and imaging. Since 2011, he has been a reviewer of grants and projects (including EU projects) in biomedical engineering.",institutionString:null,institution:{name:"University of Silesia",institutionURL:null,country:{name:"Poland"}}},subseries:[{id:"7",title:"Bioinformatics and Medical Informatics",keywords:"Biomedical Data, Drug Discovery, Clinical Diagnostics, Decoding Human Genome, AI in Personalized Medicine, Disease-prevention Strategies, Big Data Analysis in Medicine",scope:"Bioinformatics aims to help understand the functioning of the mechanisms of living organisms through the construction and use of quantitative tools. The applications of this research cover many related fields, such as biotechnology and medicine, where, for example, Bioinformatics contributes to faster drug design, DNA analysis in forensics, and DNA sequence analysis in the field of personalized medicine. Personalized medicine is a type of medical care in which treatment is customized individually for each patient. Personalized medicine enables more effective therapy, reduces the costs of therapy and clinical trials, and also minimizes the risk of side effects. Nevertheless, advances in personalized medicine would not have been possible without bioinformatics, which can analyze the human genome and other vast amounts of biomedical data, especially in genetics. The rapid growth of information technology enabled the development of new tools to decode human genomes, large-scale studies of genetic variations and medical informatics. The considerable development of technology, including the computing power of computers, is also conducive to the development of bioinformatics, including personalized medicine. In an era of rapidly growing data volumes and ever lower costs of generating, storing and computing data, personalized medicine holds great promises. Modern computational methods used as bioinformatics tools can integrate multi-scale, multi-modal and longitudinal patient data to create even more effective and safer therapy and disease prevention methods. Main aspects of the topic are: Applying bioinformatics in drug discovery and development; Bioinformatics in clinical diagnostics (genetic variants that act as markers for a condition or a disease); Blockchain and Artificial Intelligence/Machine Learning in personalized medicine; Customize disease-prevention strategies in personalized medicine; Big data analysis in personalized medicine; Translating stratification algorithms into clinical practice of personalized medicine.",annualVolume:11403,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/7.jpg",editor:{id:"351533",title:"Dr.",name:"Slawomir",middleName:null,surname:"Wilczynski",fullName:"Slawomir Wilczynski",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000035U1loQAC/Profile_Picture_1630074514792",institutionString:null,institution:{name:"Medical University of Silesia",institutionURL:null,country:{name:"Poland"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"5886",title:"Dr.",name:"Alexandros",middleName:"T.",surname:"Tzallas",fullName:"Alexandros Tzallas",profilePictureURL:"https://mts.intechopen.com/storage/users/5886/images/system/5886.png",institutionString:"University of Ioannina, Greece & Imperial College London",institution:{name:"University of Ioannina",institutionURL:null,country:{name:"Greece"}}},{id:"257388",title:"Distinguished Prof.",name:"Lulu",middleName:null,surname:"Wang",fullName:"Lulu Wang",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRX6kQAG/Profile_Picture_1630329584194",institutionString:"Shenzhen Technology University",institution:{name:"Shenzhen Technology University",institutionURL:null,country:{name:"China"}}},{id:"225387",title:"Prof.",name:"Reda R.",middleName:"R.",surname:"Gharieb",fullName:"Reda R. Gharieb",profilePictureURL:"https://mts.intechopen.com/storage/users/225387/images/system/225387.jpg",institutionString:"Assiut University",institution:{name:"Assiut University",institutionURL:null,country:{name:"Egypt"}}}]},{id:"8",title:"Bioinspired Technology and Biomechanics",keywords:"Bioinspired Systems, Biomechanics, Assistive Technology, Rehabilitation",scope:'Bioinspired technologies take advantage of understanding the actual biological system to provide solutions to problems in several areas. Recently, bioinspired systems have been successfully employing biomechanics to develop and improve assistive technology and rehabilitation devices. The research topic "Bioinspired Technology and Biomechanics" welcomes studies reporting recent advances in bioinspired technologies that contribute to individuals\' health, inclusion, and rehabilitation. Possible contributions can address (but are not limited to) the following research topics: Bioinspired design and control of exoskeletons, orthoses, and prostheses; Experimental evaluation of the effect of assistive devices (e.g., influence on gait, balance, and neuromuscular system); Bioinspired technologies for rehabilitation, including clinical studies reporting evaluations; Application of neuromuscular and biomechanical models to the development of bioinspired technology.',annualVolume:11404,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/8.jpg",editor:{id:"144937",title:"Prof.",name:"Adriano",middleName:"De Oliveira",surname:"Andrade",fullName:"Adriano Andrade",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRC8QQAW/Profile_Picture_1625219101815",institutionString:null,institution:{name:"Federal University of Uberlândia",institutionURL:null,country:{name:"Brazil"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"49517",title:"Prof.",name:"Hitoshi",middleName:null,surname:"Tsunashima",fullName:"Hitoshi Tsunashima",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYTP4QAO/Profile_Picture_1625819726528",institutionString:null,institution:{name:"Nihon University",institutionURL:null,country:{name:"Japan"}}},{id:"425354",title:"Dr.",name:"Marcus",middleName:"Fraga",surname:"Vieira",fullName:"Marcus Vieira",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003BJSgIQAX/Profile_Picture_1627904687309",institutionString:null,institution:{name:"Universidade Federal de Goiás",institutionURL:null,country:{name:"Brazil"}}},{id:"196746",title:"Dr.",name:"Ramana",middleName:null,surname:"Vinjamuri",fullName:"Ramana Vinjamuri",profilePictureURL:"https://mts.intechopen.com/storage/users/196746/images/system/196746.jpeg",institutionString:"University of Maryland, Baltimore County",institution:{name:"University of Maryland, Baltimore County",institutionURL:null,country:{name:"United States of America"}}}]},{id:"9",title:"Biotechnology - Biosensors, Biomaterials and Tissue Engineering",keywords:"Biotechnology, Biosensors, Biomaterials, Tissue Engineering",scope:"The Biotechnology - Biosensors, Biomaterials and Tissue Engineering topic within the Biomedical Engineering Series aims to rapidly publish contributions on all aspects of biotechnology, biosensors, biomaterial and tissue engineering. We encourage the submission of manuscripts that provide novel and mechanistic insights that report significant advances in the fields. Topics can include but are not limited to: Biotechnology such as biotechnological products and process engineering; Biotechnologically relevant enzymes and proteins; Bioenergy and biofuels; Applied genetics and molecular biotechnology; Genomics, transcriptomics, proteomics; Applied microbial and cell physiology; Environmental biotechnology; Methods and protocols. Moreover, topics in biosensor technology, like sensors that incorporate enzymes, antibodies, nucleic acids, whole cells, tissues and organelles, and other biological or biologically inspired components will be considered, and topics exploring transducers, including those based on electrochemical and optical piezoelectric, thermal, magnetic, and micromechanical elements. Chapters exploring biomaterial approaches such as polymer synthesis and characterization, drug and gene vector design, biocompatibility, immunology and toxicology, and self-assembly at the nanoscale, are welcome. Finally, the tissue engineering subcategory will support topics such as the fundamentals of stem cells and progenitor cells and their proliferation, differentiation, bioreactors for three-dimensional culture and studies of phenotypic changes, stem and progenitor cells, both short and long term, ex vivo and in vivo implantation both in preclinical models and also in clinical trials.",annualVolume:11405,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/9.jpg",editor:{id:"126286",title:"Dr.",name:"Luis",middleName:"Jesús",surname:"Villarreal-Gómez",fullName:"Luis Villarreal-Gómez",profilePictureURL:"https://mts.intechopen.com/storage/users/126286/images/system/126286.jpg",institutionString:null,institution:{name:"Autonomous University of Baja California",institutionURL:null,country:{name:"Mexico"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"35539",title:"Dr.",name:"Cecilia",middleName:null,surname:"Cristea",fullName:"Cecilia Cristea",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYQ65QAG/Profile_Picture_1621007741527",institutionString:null,institution:{name:"Iuliu Hațieganu University of Medicine and Pharmacy",institutionURL:null,country:{name:"Romania"}}},{id:"40735",title:"Dr.",name:"Gil",middleName:"Alberto Batista",surname:"Gonçalves",fullName:"Gil Gonçalves",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYRLGQA4/Profile_Picture_1628492612759",institutionString:null,institution:{name:"University of Aveiro",institutionURL:null,country:{name:"Portugal"}}},{id:"211725",title:"Associate Prof.",name:"Johann F.",middleName:null,surname:"Osma",fullName:"Johann F. Osma",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSDv7QAG/Profile_Picture_1626602531691",institutionString:null,institution:{name:"Universidad de Los Andes",institutionURL:null,country:{name:"Colombia"}}},{id:"69697",title:"Dr.",name:"Mani T.",middleName:null,surname:"Valarmathi",fullName:"Mani T. Valarmathi",profilePictureURL:"https://mts.intechopen.com/storage/users/69697/images/system/69697.jpg",institutionString:"Religen Inc. | A Life Science Company, United States of America",institution:null},{id:"205081",title:"Dr.",name:"Marco",middleName:"Vinícius",surname:"Chaud",fullName:"Marco Chaud",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSDGeQAO/Profile_Picture_1622624307737",institutionString:null,institution:{name:"Universidade de Sorocaba",institutionURL:null,country:{name:"Brazil"}}}]}]}},libraryRecommendation:{success:null,errors:{},institutions:[]},route:{name:"profile.detail",path:"/profiles/320030",hash:"",query:{},params:{id:"320030"},fullPath:"/profiles/320030",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()